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Abstract
The Chlamydiaceae are obligate intracellular pathogens of eukaryotic cells. These few
species are responsible for a wide variety of human and animal diseases, including
trachoma, sexually transmitted genital infections, pneumonia and abortion. Female
infertility secondary to chronic pelvic inflammation is a particularly important and
relatively common complication of C. trachomatis infection. The cysteine-rich Major
Outer Membrane Protein (MOMP) is the immunodominant chlamydial protein and a
primary vaccine target. It is predicted to function as a general diffusion porin that may
also, through intra- and/or intermolecular disulphide bond formation, play an important
structural role in maintaining stability of the organism in the absence of a peptidoglycan
layer. However, vaccine development and examining the specific biochemistry of
MOMP in situ is problematic due to difficulties involved in culturing the organisms and
the presence of other chlamydial membrane proteins.
A dual approach was taken to develop a recombinant system to express MOMP in E.
coli. Full length MOMP expressed with the E. coli ompT signal sequence was shown to
be successfully transported to the outer membrane of the cell. A proportion of the
protein solubilised from the membrane eluted as trimers during size exclusion
chromatography, and formed porin-like channels in planar lipid bilayers. Mature
MOMP lacking a signal sequence accumulated in inclusion bodies when expressed in E.
coli. These were denatured and refolded in vitro to produce higher order complexes of
11
MOMP composed of SDS resistant trimers. Cysteine residues were found to play a
critical role in the stabilisation of both secondary and tertiary structures. The ability to
express properly folded recombinant MOMPs, and other chlamydial outer membrane
proteins, will allow more detailed analysis of the structural and functional roles of
MOMPs, and contribute to the drive for vaccine development.
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1.1 Taxonomy and diseases of the Chlamydiales
The Chlamydiales are an order of bacteria, unique in that all known representatives are
obligate intracellular pathogens of eukaryotic cells. Other well-known intracellular
eubactria (eg. Rickettsia) are found in major bacterial groups where there are many
extracellular members, whereas the Chlamydiales are phylogenetically isolated (figure
1.1A) (Preston et al. 1998). For a long time, the order contained only one family and one
genus (Chlamydiaceae and Chlamydia), but recently the availability of molecular
techniques allowed a more thorough analysis that resulted in a reclassification of the
members of the order (Everett et al.l 999). Chlamydiales now contains four families;
Chlamydiaceae, Parachlamydiaceae, Simkaniaceae and Waddliaceae (figure 1.1B)
(Bush et al.2001). All four can be referred to as "chlamydiae." The family
Chlamydiaceae is split into the genera Chlamydia and Chlamydophila, and the species
within them are responsible for a wide variety of diseases in humans and animals
(Everett.2002).
Chlamydia trachomatis is one of the most commonly known species of chlamydiae.
The different serovars invade mainly cells ofmucous membranes and lymphatic tissue.
Trachoma, a disease that develops from infection of the eye, is a major cause of
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Figure 1.1: Phylogenetic relationships of the Chlamydiales. A. Consensus
phylogenetic tree constructed from small ribosomal subunits. From Preston, Haubold
and Rainey (1998). Bar indicates genetic distance, calculated by the Fitch-Margoliash
algorithm. B. Evolutionary relationships among the Chlamydiales constructed from
16S-rRNA. From Bush and Everett (2001). Arrows indicate species of particular
clinical or veterinary importance (see main text).
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every year. C. trachomatis infection is the most common sexually transmitted disease
(STD) worldwide, and can lead to serious complications such as ectopic pregnancy,
pelvic inflammatory disease and female infertility. Infections are often asymptomatic,
and so can go untreated for prolonged periods until the secondary disease is manifested.
It can also cause neonatal inclusion conjunctivitis, pneumonia and some forms of
arthritis. Chlamydia muridarum infection produces pneumonia in mice, and is important
for its use as a model for the study of infection. An enteric isolate has been found in
hamsters. Chlamydia suis infects swine, where it can cause conjunctivitis, enteritis and
pneumonia.
Chlamydophila species also cause a wide range of disease. Chlamydophila pneumoniae
has been shown to infect humans, koalas and horses. In humans, most infections
produce acute or chronic bronchitis and pneumonia. It is widespread in the community
with seroprevalence in >60% of adults. Ch. pneumoniae has also been associated with
obstructive pulmonary disease, artherosclerosis (Ward. 1995) and Alzheimers disease
(Balin et al. 1998). Chlamydophila abortus is endemic in ruminants, where the bacteria
efficiently colonise the placenta leading to late-term abortion. This presents a major
problem in the farming community. There are occasional incidences of zoonotic
abortion in women working with infected animals. Chlamydophila psittaci infects birds
where the disease is often systematic with most organs affected. The infection is passed
in the eggs and is readily transmissible to humans. Chlamydophila pecorum has been
isolated from ruminants, koalas and swine. It causes abortion, conjunctivitits, enteritis,
pneumonia and polyarthritis. Chlamydophila felis is endemic in domesticated cats.
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Infection causes conjunctivitis rhinitis and respiratory problems. Chlamydophila caviae
causes conjunctivitis in guinea pigs.
Together the species of Chlamydiaceae are a major cause of disease worldwide. In
humans, infections are often asymptomatic and persistent. Obtaining a better
understanding of chlamydial biology is essential for the development of treatment and
vaccines.
1.2 The developmental lifecycle
The Chlamydiales have a distinctive dimorphic lifecycle, typically of 2-3 days duration
(figure 1.2) (Everett.2002). The infectious agent is the elementary body (EB). EBs are
small, metabolically inactive, electron dense chlamydial forms, usually of 0.2-0.6pm
diameter. The EBs attach to the host cell, then are endocytosed into vesicles known as
"inclusions." There is no acidification or lysosomal fusion of these inclusions. Once
internalised, the EBs differentiate into the metabolically active reticulate bodies (RBs),
which can be up to 1.5pm in diameter. Nutrients are absorbed from the host cell, and
the RBs undergo several rounds of replication. RBs then differentiate back into EBs,




Figure 1.2: The Chlamydiales developmental cycle. Ususally takes 2-3 days. EBs
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Chlamydiae do not require a secondary host as the EBs are highly stable in an
extracellular environment, due to an unusual membrane structure. Chlamydiae are
Gram-negative and have both inner and outer membranes however, unlike other Gram-
negative bacteria, there is no detectable peptidoglycan layer. Instead there is a highly
cross-linked network of disulphide bonds between envelope proteins containing
numerous cysteine residues (Hatch. 1996). Extracting EBs with the mild detergent
Sarkosyl leaves proteinaceous chlamydial outer membrane complexes (COMCs) that
resemble intact, but empty, EBs (Caldwell et al. 1981). COMCs are predominantly
composed of three proteins; the Major Outer Membrane Protein, OmcA and OmcB.
1.3 Chlamydial envelope proteins
1.3.1 The Major Outer Membrane Protein (MOMP)
MOMP was first reported by Caldwell et al. as a 40kDa, surface-exposed, chlamydial
protein and the main protein in the C. trachomatis COMC, comprising over 60% of the
total (Caldwell et al. 1981). It was subsequently confirmed to be present in the other
chlamydial species, and expressed throughout the developmental cycle (Salari et
al.1981; Hatch et al.1981). Liposome-swelling assays and electrophysiological analysis
suggested that MOMP functioned as a porin, similar to those in other bacterial
membranes, eg. OmpF in E. coli (Bavoil et al.1984; Wyllie et al.1998). Circular
6
dichroism analysis of purified MOMP supported this hypothesis, with the 62% p-sheet
measured comparative to known porins.
The gene encoding MOMP (ompA) was first cloned and sequenced by Stephens et al.
(Stephens et al.1986). Subsequent analysis of the ompA genes and translated amino acid
sequences from the different species and serovars of chlamydiae revealed that MOMP is
composed of five highly conserved regions interspersed with four "variable sequence"
domains (figure 1.3). Epitope-mapping has shown that these domains correspond to the
primary immunogenic regions within MOMP and are responsible for the antigenic
differences between species and serovars (Baehr et al.1988; Yuan et al. 1989). This has
led to the hypothesis that the VS domains are surfaced-exposed loops within the
predicted porin structure.
MOMP is an unusual porin, in that it contains between 7 and 9 well-conserved cysteine
residues that play an important functional role. In the extracellular EBs, MOMP is
oxidised and highly cross-linked, and the outer membrane is largely impermeable and
very osmotically stable. In contrast RBs are osmotically fragile and most of the MOMP
is monomelic (Hatch et al.1984). The pore-forming ability of MOMP was increased
almost tenfold when fully reduced (Bavoil et al.1984). Together these suggest that
MOMP as a porin can be opened and closed by the breaking and reforming of disulphide
bonds. This is linked to the developmental stage of the bacteria. EBs treated with
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namely increased metabolic activity, reduced infectivity, decreased osmotic stability and
a change in staining properties (Hackstadt et all985)). The reducing agent was not
sufficient in itself to initiate differentiation of the EBs into RBs, however the reduction
of the disulphide network, perhaps as a result of reducing conditions within the inclusion
vesicle, is likely to be an important early step of the process. The increased flexibility of
the membrane would be essential for the RBs to grow and divide. MOMP solubilised
from EBs and RBs in the presence of reducing agent ran as a monomer on SDS-PAGE.
However MOMP solubilised in non-reducing conditions was detected as monomers,
dimers, trimers, tetramers and as larger complexes that did not enter the polyacrylamide
gel (Newhall et al.1983; Hackstadt et al.1985). Purified MOMP has been shown to run
as a probable trimer on SDS-PAGE (McCafferty et al.1995; Wyllie et al.1998). The
precise oligomeric state of MOMP seems to be complex, involving disulphide bonds,
and differing between chlamydial species and developmental stages.
MOMP may have a further role in chlamydial biology as an adhesin during the initial
attachment of the EB to the host cell. It seems likely that attachment is a complex
process involving numerous chlamydial and host molecules. N-acetylneurminc acid, N-
acetylglucosamine, heparan sulphate and a glucosamino glycan produced by the
chlamydiae themselves have all been implicated (Zhang et al.1992; Taraktchoglou et
al.2001; Wuppermann et al.2001). There is also evidence that MOMP plays a role in
attachment. Trypsin digestion of C. trachomatis MOMP and antibody-blocking of VS2
and VS4 have been shown to inhibit the infectivity of EBs (Su et al. 1988; Su et
al.l 990b). Additionally, MOMP is N-glycosylated with mannose oligosaccharide, a
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sugar that can competitively inhibit the attachment of EBs to HeLa cells. Mannose-
binding protein also has a protective effect (Swanson et al.1994; Swanson et al.1998). A
comparison of infection ofmannose-receptor positive and negative mouse macrophages
showed different preferences for binding by several chlamydial species (Kuo et al.2002).
It seems likely that the species of chlamydiae would display differences in attachment as
they have evolved to predominantly infect different cell and tissue types. These findings
indicate that MOMP may be involved in both specific and non-specific interactions
during attachment to the host cell. Although it is likely that other molecules are also
involved, the prevalence of MOMP on the surface of the bacteria would make its role
significant.
Antigenic analysis has demonstrated that MOMP is the immunodominant chlamydial
protein (Zhang et al.l987) and as such is considered to be a primary vaccine target.
Early studies showed that antibodies raised against C. trachomatis MOMP had a
neutralising effect on the infectivity of EB in cell culture (Caldwell et al.l982). Several
approaches have been taken to creating a vaccine based on MOMP with varying degrees
of success including intact EBs, COMCs, MOMP and DNA vaccination with ompA
(Sandbulte et al.l996; Zhang et al.l997; Penttila et al.2000; Dong-Ji et al.2000; Pal et
al.2001), and although no fully protective vaccine has yet been developed encouraging
progress has been made (Christiansen et al.2002). It has been shown that Thi immune
responses and interferon-y (IFN-y) play a more critical role both in clearance of primary
infection and protection against secondary infection than humoral immunity (Johansson
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et al.l 997a; Johansson et al. 1997b). Several epitopes that stimulate T-cell proliferation
have been identified in MOMP, again within the VS domains (Su et al.1990a; Allen et
al.l991; Ishizaki et al.l992), but these have been focussed on obtaining high antibody
titre, a TH2 response. However, a T-cell epitope has been identified on MOMP that
elicits a proliferation of CD4+ and CD8+ T-cells and the production of IFN-y (Stagg et
al.l993; Knight et al.l995), that may be useful for further vaccine development.
1.3.2 The Cysteine Rich Proteins (CRPs)
The other main components of the COMC are the two cysteine rich proteins, OmcA and
OmcB, in an ratio of approximately 1 OmcB:2 OmcA:5 MOMP (Everett et al. 1991).
Both genes are encoded by a bicistronic operon and are only expressed late in the
developmental cycle as the RBs are reorganising into EBs (Newhall.1987; Lambden et
al.l990). In Ch. psittaci, OmcA is a small protein of 12kDa, yet contains 14 cysteine
residues and is predicted to be a lipoprotein (Everett et al.1994). OmcB is a 60kDa
protein that is post-translationally modified to give a doublet on SDS-PAGE (Allen et
al.l989), and contains 37 cysteine residues. The sequences of both proteins are well
conserved (Watson et al.1989; de la Maza et al. 1991). Although both proteins are in the
Sarkosyl-insoluble COMCs, this is as a result of the disulphide cross-linking and not
because they are integral membrane proteins. Under reducing conditions, OmcB
partitioned into the aqueous rather than the detergent phase, and though OmcA remained
associated with the membrane, it was soluble in Sarkosyl (Everett et al.l995). Neither
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protein could be detected by immunogold labelling on the cell surface of intact EBs
(Collett et all989; Watson et al.1994; Mygind et al.1998). It has therefore been
proposed that in EBs OmcB is extensively cross-linked in the periplasm, and forms
disulphide bonds to MOMP and to OmcA, which is associated with the inner leaflet of
the bilayer (Everett et al.1995). In RBs the CRPs are not expressed and MOMP is
reduced and functioning as a porin, allowing the influx of nutrients from the host cell
and the expansion of the bacterial cell.
1.4 Recombinant MOMP
A major obstacle to the study of MOMP is the difficulty in obtaining useable quantities
of purified protein. As chlamydiae must be grown intracellularly and at a high level of
containment, culturing the organisms in large numbers is both technically difficult and
expensive. Additionally, the interactions of MOMP with the other CRPs in the COMC
make it difficult to ensure that experimental data are attributable to MOMP alone. For
these reasons a recombinant system of expression would be preferable.
Several attempts have been made to express full length MOMP in E. coli. Most have
taken the approach of cloning the full length ompA gene including the signal sequence,
in order to target the translated protein to the E. coli outer membrane. Dascher et al. and
Manning et al. demonstrated the expression, translocation across the inner membrane,
and signal peptide cleavage of MOMP (Dascher et al.1993; Manning et al. 1993).
However, both groups found that the protein was not surface expressed and concluded it
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was instead misfolded and aggregated in the periplasm. Similarly Kaul et al. produced
translocated and processed MOMP that was associated with the outer membrane (Kaul
et al. 1990). However they provided no evidence of surface exposure and did not test for
native conformation of the protein. Koehler et al. showed a portion of expressed
MOMP was surface-exposed by immunodetection, however there was a dramatic loss of
cell viability in this system during expression (Koehler et al.1992), so cell lysis or
disrupted membranes may have affected the data. The results therefore should be
interpreted with caution. Finally, Jones et al produced a synthetic MOMP gene
expressed in E. coli. Again the protein was localised to the outer membrane, but neither
surface-exposure nor native conformation was examined (Jones et al.2000). Wyllie et
al. produced truncated versions of Ch. abortus and Ch. pneumoniae MOMP and
successfully extracted small quantities from inclusion bodies in detergent (Wyllie et
al.1999). However, this method does not provide enough protein for many downstream
analysis techniques.
Expression systems other than E. coli have been tried. Recombinant MOMP has been
expressed in COS cells (Vanrompay et al.1998) and in Vibrio cholerae (Eko et al.2003)
for use as vaccine delivery vechicles. Both showed promising signs of surface exposure,
but face the same difficulties in obtaining native conformation as MOMP expressed in
E. coli.
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A practical method of expression of recombinant MOMP has yet to be developed. The
availability of such a system would greatly aid the development of vaccines and the
study ofMOMP and chlamydial biology.
1.5 PorB
PorB is another putative porin expressed in the chlamydial outer membrane. It is
smaller than MOMP with a molecular weight of 37kDa. It is much less abundant in the
membrane than MOMP but is also expressed throughout the developmental cycle (Kubo
et al.2000). Immunodetection experiments on intact EBs confirmed PorB was surface-
exposed and antibodies raised against the antigenic regions of the protein were able to
neutralise in vitro infectivity (Kawa et al.2002). Antibodies against PorB have been
identified in human sera (Sanchez-Campillo et al.1999). It is therefore considered to be
a second possible vaccine target. Although there is much less PorB in the chlamydial
outer membrane than MOMP, it has the advantage of better sequence conservation
between serovars (Kubo et al.2000).
Due to its low abundance, it has been proposed that PorB is a substrate-specific rather
than a general diffusion porin. Recombinantly expressed PorB was shown to be specific
for 2-oxogluterate and other select dicarboxylates (Kubo et al.2001). However, in this
system the PorB was expressed with a C-terminal His tag. As the N- and C-terminals of
porins generally meet in a (3-strand it is difficult to see how the His tag could fail to
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affect folding and/or function of the porin. The precise specificity of PorB should
therefore not be assumed until confirmed by alternate methods.
PorB is an attractive secondary vaccination target due to its immunogenicity and relative
conservation. Additionally, its role as a substrate-specific porin may be important in
chlamydial-host interactions.
1.6 Study aims
The central aim of this study was to establish a recombinant system for the expression of
MOMP in its native fold. Protein obtained would then be used to investigate the
structural and functional properties of MOMP. If possible, the system could be
expanded to also express other chlamydial outer membrane proteins.
Two basic approaches were taken simultaneously to expressing MOMP in E. coli. The
first approach was to express MOMP without a leader sequence as insoluble inclusion
bodies in the bacterial cytoplasm. Protein would then be solubilised and denatured, and
refolded in vitro. The second approach was to express MOMP directly to the E. coli
outer membrane, targeting it using either MOMP's own leader sequence or a leader
sequence from a known E. coli outer membrane protein. Developing two different
methods was intended to increase the likelihood of success, as MOMP has proved
difficult to produce recombinantly in the past.
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This thesis outlines the methodology used and the level of success of these expression
systems. The different properties of MOMP within these systems are also examined.
The study furthers the understanding of the biochemistry of chlamydial MOMP and
contributes to the drive for vaccine development.
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Chapter 2: Materials and methods
2.1 Materials
Unless otherwise indicated, chemicals were supplied by either Sigma Aldrich or Fisher,
detergents and lipids were supplied by Anatrace, and enzymes were supplied by New
England Biolabs Inc.
2.2 Prediction algorithms
Three artificial neural network-based secondary structure prediction algorithms were
used to analyse MOMP. Firstly, the Diederichs outer membrane protein topology
prediction program, available at:
http://strucbio.biologie.uni-konstanz.de/~kay/om_topo_predict2.html
using the new set of weights (Diederichs et al.1998). Secondly, the TMBETA
transmembrane p-strand prediction program (Gromiha et al.2004), available at:
http://psfs.cbrc.jp/tmbeta-net/




2.3 Agarose gel electrophoresis
DNA was separated by agarose gel electrophoresis. Gels were prepared by mixing 1%
(w/v) agarose powder in TBE (45mM Tris-borate ImM EDTA) and heating until the
agarose dissolved. 0.5p,g/ml ethidium bromide was added, and the molten agarose
poured into moulds and allowed to set. DNA was mixed 1:1 with loading buffer (75mM
Tris-HCl pH 7.6, 30% (v/v) glycerol, 1.25mg/ml bromophenol blue) and loaded into the
wells. Electrophoresis was carried out at 150V using a Biorad PowerPac 3000, in a
Biorad Sub Cell GT tank. Gels were viewed on a UVP GelDoc UV transilluminator.
2.4 Polymerase chain reaction (PCR)
2.4.1 Gene amplification
The porB gene, with and without its leader sequence, was amplified directly from C.
muridarum genomic DNA (kindly provided by Dr Richard S Stephens and colleagues,
UC Berkeley, CA). Primers were designed at the 5' and 3' ends of the gene. The sense
primers contained a 5' overhang of the restriction site Nde-l (using the start codon as its
internal ATG) plus enough extra bases to allow subsequent restriction digest (New
England Biolabs Inc.2002). The same anti-sense primer was used for both constructs
and recognised downstream of the stop codon and included the restriction site Nco-l plus
extra bases to provide an overhang for digest.
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PCR was carried out using approximately lOng of genomic DNA, 25pmol sense primer
and 25pmol anti-sense primer in a 50pl reaction also containing 20mM Tris-HCl pH8.8,
lOmM (NH4)2S04, lOmM KC1, 0.1% (v/v) Triton X-100, O.lmg/ml BSA, 2mM MgS04,
0.2mM dNTPs and 3U Pfu polymerase. A 5min denaturing hold at 94°C was followed
by 25 cycles of 30sec at 94°C, 30s at the annealing temperature (see appendix B) and
2min at 72°C, then a final extension of 7min at 72°C.
2.4.2 Site-directed mutagenesis (SDM)
2.4.2.1 SDM of plasmid DNA
The ompA gene from C. trachomatis had already been cloned into the pSTBlue-1
plasmid (R.H. Ashley, unpublished data). For cloning into the expression vector the
restriction site at the 5' end of the gene was changed to Nde-1 and an internal Nde-l site
was removed. These mutations were introduced using the QuikChange method
(Stratagene). Overlapping primers were designed to contain the desired mutation with
approximately 10-20 base pairs either side of the mutation site. ~10ng of plasmid,
12.5pmol sense primer and 12.5pmol anti-sense primer was added to a 50 pi reaction
mix (as in section 2.4.1) and amplified around the entire plasmid with a standard
protocol of 18 cycles consisting of 30sec at 94°C, 30sec at the annealing temperature and
lOmin at 72°C.
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The product was digested with Dpn-l for lhr at 37°C to degrade the template DNA then
transformed into Novablue cells (Novagen).
The same method was used to create the cysteine-less mutant and the internal
mutagenesis in C. trachomatis ompA. All nine cysteine residues in C. trachomatis
MOMP were mutated to alanine residues in the pSTBlue-1 cloning vector, before
subcloning into the pET22b(+) expression vector. Also in the cloning vector, unique
restriction sites were introduced either end of each VS domain, allowing subsequent
digestion and removal from the gene (see appendix B).
2.4.2.2 SDM from genomic DNA
The ompA gene of C. muridarum was amplified directly from genomic DNA, but
required the removal of an internal Nde-l site during initial amplification to allow
subsequent cloning into the pET22b(+) vector. Four primers were designed; two cloning
primers and two overlapping mutation primers as described above, making a single base
pair change to destroy the Nde-l site. The sense cloning primer contained an Nde-l
restriction site and the anti-sense cloning primer contained a BamR I restriction site.
One reaction was set up using the sense cloning primer and the anti-sense mutation
primer, and a second using the sense mutation primer and the anti-sense cloning primer.
Both reactions were carried out in the conditions described in the previous section, over
18 cycles of 30sec at 94°C, 30sec at the annealing temperature and 2min at 72°C. The
products were separated by agarose gel electrophoresis then purified by gel extraction.
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1pi of each gel-purified product was added to a third PCR reaction without any primers
but the same other conditions, and amplified for 8 cycles. The reaction mix was then
spiked with 25pmol of each of the two cloning primers and continued for another 20
cycles.
2.4.3 Gene extension
The native chlamydial and ompT E.coli leader sequences were added to the 5' end of
genes by sequential PCR. A series of three overlapping sense primers were made, each
adding more of the leader sequence on the 5' end of the gene. The third primer
contained the start codon and an Nde-l restriction site. One anti-sense primer was made
containing an Nco-l site. 12.5pmol of sense primer 1 and 12.5pmol anti-sense primer
were added to a 50pl reaction tube also containing ~10ng template DNA and the same
buffer conditions as before. Amplification was by the standard 18 cycle protocol. The
product was separated by agarose electrophoresis and purified by gel extraction, lpl of
this was used as the template for the second round of PCR using sense primer 2. This
was repeated with sense primer 3 to give the complete product.
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2.5 Gel purification
Bands were excised from the agarose gel and purified using a DNA-binding
Perfectprep™ Gel Cleanup Kit (Eppendorf) according to the manufacturer's
instructions. DNA was routinely eluted in the smaller recommended volume of 30pl.
2.6 Restriction digestion
2.6.1 Sequential digest
The pET22b(+) vector was prepared for cloning by long sequential digest, to maximise
the yield of double digested DNA, when the restriction sites are close to each other.
Similarly, the sticky ends of genes for cloning directly into pET22b(+) were prepared by
this method because of the reduced efficiency of digestion near the end ofDNA strands.
A 20pl reaction was set up containing 3pg vector, or 1 OjlxI gel-purified insert, 50mM K-
acetate, 20mM Tris-acetate, lOmM Mg-acetate, ImM DTT, pH 7.9 and 10U Nco-1 and
incubated at 37°C overnight. With the C. muridarum clones, a similar reaction was set
up with vector/insert, 150mM NaCl, lOmM Tris-HCl, lOmM MgCl?, ImM DTT,
O.lmg/ml BSA, pH 7.9 and 10U BamH-I and also incubated overnight at 37°C. In each




For subcloning, the DNA was cut out by double digest. 3gtg of plasmid was added to a
20pl reaction buffered as for sequential digestion, but withlOU Nco-l and 10U Nde-l
added, then incubated for 3hr at 37°C. The products were separated by agarose gel
electrophoresis and the insert gel purified.
2.6.3 Domain digest
The VS domains were digested out of the C. trachomatis ompA gene by adding 3pg of
DNA to a 20pl reaction containing 2pl lOx reaction buffer and 20U of the relevant
restriction enzyme and incubated at 37°C or 50°C (Bcl-l) for 3hr.
2.7 Alkaline phosphatase
Phosphate groups were removed from the cut ends of vectors to prevent re-ligation
giving rise to false positives. 1U of shrimp alkaline phosphatase (Helena Biosciences)
was added per pmol end of vector in 50mM Tris-HCl pH 8.5, 5mM MgCh according to
the equation:
pmol ends (linear double stranded DNA) = x 3.04■* ' '11 T~v ~\ T J
kbDNA
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and incubated for lOmin at 37°C. The alkaline phosphatase was removed using a




Alkaline phosphatased pET22b(+) and the gel purified insert genes were ligated in a
1 OjlxI reaction containing lpl vector, 50mM Tris-HCl pH 7.5, lOmM MgCh, lOmM
DTT, ImM ATP, 25pg/ml BSA, 3pi insert and 3U of T4 DNA Ligase (New England
Biolabs), and incubated overnight at 16°C. The ligase was inactivated by heating for
lOmin at 70°C, then 3U Msc-l was added and the reaction incubated at 37°C for 3hr. In
the pET22b(+) multiple cloning site, the Msc-l site is between the Nde-l and Nco-l
restriction sites, and therefore the enzyme will only digest empty vectors that would give
rise to negative colonies.
2.8.2 Domain deletion
Digested C. trachomatis ompA in vector pSTBlue-1 was re-circularised without the
deleted domain, in a 10pl ligation reaction containing lpl DNA, in the same reaction
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conditions as above, and incubated at 16°C overnight. The mutagenised ompA gene was
then subcloned into pET22b(+).
2.9 Preparation of media and agar
2.9.1 Luria-Bertani medium and agar
Luria Bertani (LB) medium was prepared by mixing 0.5% (w/v) yeast extract, 1% (w/v)
bactotryptone and 0.5% (w/v) NaCl in dH20, and buffering to pH 7.4 using NaOH. LB
agar was made by adding 15% (w/v) agar powder to LB media. The media and agar
were aliquoted into flasks and autoclaved. To make agar plates, ampicillin was added to
the concentration of lOOpg/ml to the liquid agar then poured out approximately 20ml per
plate into petri dishes, the surface flame sterilised, and allowed to set.
2.9.2 SOC medium
SOC medium was made by mixing 0.5% (w/v) yeast extract, 2% (w/v) bactotryptone
and 0.05% (w/v) NaCl in dH20 and buffering to pH 7.0 using NaOH. The media was
aliquoted into flasks and autoclaved. Directly before use 5ml sterile 2M MgCl2 and




Bacteria were stored as glycerol stocks at -70°C. To make these, a single colony of
transformed bacteria was picked with a toothpick or a pipette tip and grown overnight in
5ml LB media, containing antibiotic where appropriate. This culture was re-seeded
1:100 into fresh media and grown until mid-exponential phase (OD600 = 0.6). Sterile
glycerol was added to 10% (v/v) and the cells were aliquoted into sterile 2ml tubes and
frozen rapidly in a mix of dry ice and isopropanol.
2.10.2 Competent cells
Cells were scraped from a glycerol stock and added to 5ml of LB media and grown at
37°C overnight. For Novablue (Novagen) and Aomp8 cells, 10pg/ml tetracycline was
added to the media. 2.5ml of this culture was added to 250ml fresh LB media, again
containing tetracycline where appropriate, and grown with shaking at 37°C until it
reached OD600 -0.4-0.6. The cells were harvested by centrifuging for 5min at 4500 x g
at 4°C in a sterile container. The resulting pellet was re-suspended in 100ml TFB1
buffer (30mM potassium acetate, lOmM CaCl2, 50mM MnCri, lOOmM RbCl2, 15%
(v/v) glycerol, pH 5.8) and incubated on ice for 5min. The cells were pelleted as before
then re-suspended in 10ml TFB2 buffer (lOmM MOPS, 75mM CaCh, lOmM RbC^,
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15% (vv) glycerol, pH 6.5) and incubated on ice for 15-60min. 200pl aliquots were
transferred into sterile 1.5ml tubes and rapidly frozen in dry ice/isopropanol then stored
at -70°C.
2.11 Transformations
Aliquots of competent cells were thawed on ice, then l-5pl DNA was added and the
cells incubated on ice for 30min. The bacteria were heat shocked for 45sec at 42°C then
incubated on ice for a further 2mins. 200jil of fresh medium was added, followed by
incubation at 37°C for 15-30min with shaking. lOOpl of transformed cells were plated
out onto agar plates containing 100|_ig/ml ampicillin, and incubated overnight at 37°C.
2.12 DNA preparation
Mini, midi and maxi preparations of DNA (with maximum yields of 20, 200 and 500pg
respectively) were made using the QIAprep® Miniprep Kit, HiSpeed™ Plasmid Midi





Transformed colonies were screened for the presence of the inserted gene by PCR
amplification using the relevant cloning primers. Each reaction totalled 50pl and
contained lOmM Tris-HCl pH 9.0, 50mM KC1, 1% (v/v) Triton-X-100, 1.5mM MgCl2,
25pmol sense primer, 25pmol anti-sense primer, 1 pi dNTPs and 2.5U Taq DNA
polymerase (Promega). A colony was picked using a toothpick/pipette tip and spotted
onto an agar plate, which was incubated overnight at 37°C. Remaining cells were then
shaken off into the PCR reaction mix. Amplification consisted of a 5min hold at 94°C,
25 cycles of 30sec at 94°C, 30sec at the annealing temperature and 30sec at 72°C, and
finally a 7min hold at 72°C. Positive colonies were determined by agarose
electrophoresis of the PCR products, then cultured from the agar plate.
2.13.2 Hemi-nested screen
The successful deletion of a domain was tested by a hemi-nested PCR. Reaction mixes
were set up containing lOmM Tris-HCl pH 9.0, 50mM KC1, 1% (v/v) Triton-X-100,
1.5mM MgCb, lpl dNTPs and 0.5pl Taq polymerase. 25pmol 5' sense mutagenesis
primer, 25 pmol 3' anti-sense cloning primer and ~10ng DNA was added. Clones where
the section between the two mutagenesis sites has been digested away were unable to
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amplify compared to the positive control. Amplification conditions were as in the
previous section.
2.14 Protein expression
2.14.1 Mature protein (lacking a signal sequence)
Constructs without signal sequences were transformed into BL21(DE3) cells (Novagen)
and Aomp8 cells, and stored as glycerol stocks.
A scraping of glycerol stock was added to 5ml of LB media, containing lOOpg/ml
ampicillin. Aomp8 cells also had lOpg/ml tetracycline added. This was grown
overnight at 37°C with shaking, then reseeded 1:100 into 250ml fresh LB media
containing ampicillin. This was incubated at 37°C until the ODgoo = 0-6. Cells were
harvested by centrifugation at 6000 x g for 5mins in a Beckman Avanti™ J-25
centrifuge, and re-suspended into fresh LB media containing ampicillin. The culture
was replaced in the 37°C incubator and allowed to equilibrate to temperature for lOmin.
Isopropyl P-D-thiogalactopyranoside (IPTG) was added to a final concentration of ImM
to induce the plasmid, and the culture incubated for a further 3hr at 37°C.
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2.14.2 Full length protein (with a signal sequence)
Full length constructs were also transformed into BL21s and Aomp8 cells and glycerol
stocks prepared. An overnight culture in LB was grown to saturation overnight as for
mature protein. This was re-seeded 1:100 into 1 litre of SOC medium containing
lOOpg/ml ampicillin and incubated at 37°C until the ODeoo = 0.6. A media change was
carried out as described in the previous section. The cells were resuspended into 1 litre
of fresh SOC with antibiotic and incubated at 16°C for lOmin. IPTG was added to a
final concentration of 0.1mM and the culture incubated at 16°C overnight.
2.15 Inclusion body preparation
Cells were harvested from induced cultures by centrifugation at 6000 x g for 5min and
washed in 50ml phosphate buffered saline (PBS). The pellet was resuspended in 5ml of
TEN buffer (50mM Tris, lOmM EDTA, lOOmM NaCl, pH 8.0) and 0.2mg/ml lysozyme
added. After a 30min incubation at room temperature, cells were lysed by sonicating
with 6 x 15sec blasts at 6pm using a Sanyo Soniprep 150 sonicator.
Membrane-associated proteins in the cell lysate were solubilised by incubation for
30min at 37°C with 0.8mg/ml sodium deoxycholate. Nucleic acids were degraded by
incubation for 15min at room temperature with 20U/ml Benzonase (Novagen). The
inclusion bodies were isolated by centrifugation at 12,000 x g for lOmin. The resulting
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whitish pellet was washed repeatedly with 10ml IB wash buffer (TEN buffer, with 2M
urea, 1% (v/v) Triton-X-100) until the supernatant was colourless. A final wash with
10ml TEN buffer removed traces of urea and detergent. The IB pellet was dissolved in
2ml of 6M GuHCl with lOmM DTT. This solution was ultracentrifuged for 20min at
100,000 rpm (-300,000 x g) in a Beckman TL100 Ultracentrifuge to pellet any large
aggregates and remaining cellular debris.
2.16 Outer membrane protein isolation
Cells were harvested and lysed by sonication as in the inclusion body preparation. The
cell lysate was incubated with with 20U/ml Benzonase for 15min at room temperature.
The outer membrane fragments were pelleted by centrifugation at 15,000 x g for lOmin
and the supernatant discarded. The pellet was washed twice in 20ml TEN buffer.
Membrane proteins were extracted by resuspending the pellet in 6ml solubilisation
buffer (50mM Tris pH 8, ImM EDTA, 50mM NaCl, lOmM DTT, 1% (v/v) detergent)
and incubating at 37°C for lhr. The solution was clarified by ultracentrifuging for
20min at 100,000 rpm.
2.17 Protein concentration assay
The concentration of protein was determined using the Marwell-Lowry assay (Markwell
et al.1978) to avoid interference from detergent and lipid. Three samples of a 1:10
dilution of denatured protein, of 30pl, 15pl and 7.5pl were aliquoted into 1.5ml tubes.
31
In addition, a set of standards were set up containing 0, 5, 10, 15, 20, 25pg bovine serum
albumin. To each tube was added 50pl of lOmg/ml Na-deoxycholate, before vortexing.
lml of 10% (w/v) trichloroacetic acid was added to each tube, which were vortexed
again then centrifuged for 2min at 13,000 rpm in a Biofuge pico (Heraeus Instruments)
benchtop centrifuge. The supernatant was discarded. Alkaline copper reagent was
freshly prepared from a 100:1 mixture of solution A (200mM Na2CC>3, lOOmM NaOH,
7mM K Na Tartrate, 1% (w/v) SDS) with solution B (4% (w/v) CUSO4.5H2O). The
pellets were resuspended in lml alkaline copper reagent. lOOpl of a 1:1 dilution of Folin
Reagent in dF^O was added with each tube being vortexed immediately. After lhr
incubation at room temperature the A750 was measured. The standards absorbances were
plotted and the protein concentration calculated.
2.18 Sodium dodecyl sulphate polyacrylamide qel electrophoresis (SDS-PAGE)
Proteins were separated by polyacrylamide gel electrophoresis using the Biorad Protean
3 Mini Gel System. 10% or 12% separating gels were prepared from 40% (w/v)
acrylamide/bis-acrylamide (37.5:1) solution in 375mM Tris pH 8.8, 0.1% (w/v) sodium
dodecyl sulphate (SDS), 0.1% (w/v) ammonium persulphate (APS) and 0.1% (w/v)
N,N,N',N'-tetramethylethylenediamine (TEMED). Stacking gels were composed of 4%
(w/v) acrylamide/bisacrylamide, 125mM Tris pH 6.5, 0.1% SDS (w/v), 0.1% (w/v) APS
and 0.1% (w/v) TEMED. Gels were run at 150V on a Biorad PowerPac 300 for 60-
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120min. Precision Plus Unstained Protein Markers and Kaleidoscope Pre-stained
Protein Markers (BioRad) were used as molecular weight standards.
2.19 Staining
2.19.1 Coomassie stain
Polyacrylamide gels were stained for 30min in 40% (v/v) methanol, 10% (v/v) acetic
acid, 0.25% (w/v) Brilliant Blue R-250, then destained by several changes of 40% (v/v)
methanol, 10% (v/v) acetic acid.
2.19.2 Colloidal stain
Polyacrylamide gels were stained with
several changes of dfUO.
GelCode (Pierce) for lhr, then destained by
2,20 Western blot
2.20.1 Wet transfer
Gels were transferred on to Hybond-P polyvinylidene di fluoride (PVDF) membranes
(Amersham Biosciences) pre-activated by washing for lOsec in methanol. Transfers
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were carried out on ice in a Mini Trans-Blot Cell tank transfer system (Biorad) for
60min at 100V on a PowerPac 300 power supply.
2.20.2 Blotting
Membranes were blocked for 30min at room temperature or overnight at 4°C in 5%
(w/v) Marvel in PBS-T (0.005% (v/v) Tween 20 in PBS) then incubated in a 1:5000
dilution of goat anti-trachomatis MOMP antibody (Fitzgerald International, Inc) for lhr
at room temperature. The primary antibody was removed with 2 x 30sec washes and 3 x
5min washes of PBS-T. Membranes were incubated in a 1:10,000 dilution of HRP-
conjugated anti-goat/sheep antibody (Sigma) for lhr at room temperature. The
secondary antibody was washed off as before.
2.20.3 Detection
Western blots were visualised by electrochemiluminescence (ECL). Equal volumes of
ECL solution 1 (lOOmM Tris-ElCl pH 8.5, 2.5mM luminol, 0.4mM coumaric acid) and
solution 2 (lOOmM Tris-HCl pH 8.5, 0.019% (v/v) H2O2) were combined and the
membrane incubated in the mixture for lmin. In a dark room the membrane was
exposed to medical film (Konica) for 15sec to 30min. The film was developed in a
Konica SRX-101A X-ray developer.
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2.21 Dot Blots
2.21.1 Whole cell immunoblots
A fresh glycerol scraping was added to 5ml of LB media containing 100pg/ml
ampicillin and incubated at 37°C overnight. This was re-seeded 1:100 into 10ml fresh
media and antibiotic and grown at 37°C until OD = 0.6. The media was changed by
centrifuging the culture for lOmin at 6000 x g, discarding the supernatant and
resuspending the cells in fresh media and antibiotic. The culture was incubated at 25°C
for lOmin, then ImM IPTG was added and it was incubated for a further 2hr.
Intact cells were harvested by centrifuging for 5min at 4500 x g and washed in 1ml PBS.
The pellets were resuspended in 200pl PBS. 10pl was spotted on to nitrocellulose
membrane (Biorad) and allowed to dry. The membrane was then blocked, blotted and
exposed as for Western blotting.
2.21.2 Dot blots
Preactivated PVDF membrane was allowed to air dry. lOpl protein samples were dotted
onto the membrane. After drying, the protein was fixed by a 5min incubation in
methanol and the membrane rinsed in dPLO. The membrane was then blocked, blotted
and exposed as for Western blotting.
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2.22 Chromatography
A Pharmacia FPLC™ system was used for Fast Performance Liquid Chromatography.
Gel filtration chromatography was carried out on a HR 26/60 FliLoad Superdex 200 prep
grade column (Amersham Biosciences). The column was pre-equilibrated with 2
column volumes of equilibration buffer (50mM Tris pH 8.0, ImM EDTA, 50mM NaCl,
5mM DTT, 0.05% (w/v) LDAO or Zwittergent 3,14). 2ml of solubilised outer
membrane protein was applied and the column run with equilibration buffer for 800min
at a flow rate of 0.5ml/min. 5ml fractions were collected on a FRAC-200 fraction
collector.
2.23 Planar lipid bilayer
A suspension of diphytanoyl phosphatidylcholine in decane was used to form bilayers
across a 0.3mm hole in a polystyrene partition separating two solution filled chambers.
Bilayers used had a capacitance of 200-300pF and a conductance of 5-10pS. Both
chambers were filled with 50mM KC1, lOmM Tris, pH 7.4 and ImM DTT and the "cis"
chamber was voltage-clamped at OmV using an Axopatch 200B amplifier. The "trans "
chamber was grounded. Channel incorporation was induced by adding aliquots of 3M
KC1 to the cis chamber to give a concentration gradient of 500:50 mM KC1 cis:trcins,
before adding ~lng/ml MOMP to the cis chamber, then repeatedly switching the
membrane potential between +60 and -60mV. Following the appearance of unit
transmembrane currents, implying channel insertion into the membrane, the cis chamber
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was perfused with a minimum of 10 volumes of 50mM KC1, lOmM Tris,pH 7.4, to
minimise the incorporation of further channels. Subsequent changes in salt
concentration were effected by the addition of 3M KC1 aliquots or perfusion, as
required.
Traces were low-pass filtered 50Hz-lkHz (8 pole Bessel filter), and digitally recorded
and analysed using pClamp 8 software.
2.24 Circular dichroism
Samples were dialysed into 50mM sodium phosphate pH 8.0, containing 2mM DTT and
detergent at a concentration slightly above its critical micelle concentration (CMC).
Circular dichroism spectra were obtained in a Jasco J-810 spectropolarimeter using 0.05
cm cells, scanning between 260nm and 190nm at lOnm/min and a data pitch of 0.2nm.
For each sample, 5 spectra were accumulated, the buffer-only baseline spectrum was
subtracted and the data were analysed using CDSSTR (Compton et all986; Manavalan
et al.1987), CONTINLL (Provencher et al. 1981) and SELCON3 (Sreerama et al.1993)
and reference set 7 (Sreerama et al.2000a; Sreerama et al.2000b) from the Dichroweb
website (Lobley et al.2002).
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Chapter 3: Secondary structure and topology predictions of C. trachomatis
MOMP
3.1 Neural Network Topology Prediction
The sequence of C. trachomatis MOMP was analysed using an artificial neural network
that had been trained with a set of outer membrane porins of known, high-resolution
structure (Diederichs et al.1998). The neural network predicts the z-coordinate of porin
amino acids in a frame where the xy plane is the outer membrane and the
transmembrane pore is aligned along the z-axis. Low z-values, <0.4, are predicted to
correspond to residues in periplasmic turns and high z-values, >0.6, to residues in
extracellular loops. Residues predicted to be in the transmembrane [j-strands have
values between these extremes.
A graph of these calculated z-coordinates against the sequence residue numbers was
plotted (figure 3.1 A, see appendix A.l for original data). The resulting curve showed
several clear maxima and minima, suggesting the position of the turns and loops. Of
particular interest was the association of the VS domains with extracellular regions of
the protein, as has been frequently inferred from other experimental data. However,
there were regions of the plot where the positioning of loops and strands was less clear,
so further prediction methods were applied to the sequence.
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Figure 3.1: Secondary structure predictions of C. trachomatis MOMP. A.
Diederichs topology prediction. The lines at 0.4 and 0.6 indicate the borders
between predicted periplasmic and transmembrane residues, and extracellular and
transmembrane residues respectively. B. TMBETA transmembrane (3-strand
prediction. Blocks indicated predicted strands. C. B2TMPRED transmembrane (3-
strand prediction. The four VS domains are high-lighted.
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3.2 Transmembrane B-strand Prediction
Two different prediction algorithms were used to identify potential transmembrane (3-
strands in C. trachomatis MOMP; TMBETA (Gromiha et al.2004) and B2TMPRED
(Jacoboni et al.2001). Both these programs were again artificial neural network based.
The results were mapped out against the residue number allowing comparisons to be
drawn (figure 3.IB, 3.1C, appendices A.2 and A.3 for full data). TMBETA predicted 13
transmembrane strands, and B2TMPRED 14 strands. Many of these were identified by
both algorithms, however there were some differences between the two outcomes, for
example a strand was predicted between residues 11-20 in TMBETA that was not
identified by B2TMPRED. Again it was noticeable that the VS domains were almost
entirely free from |3-strands in these predictions.
3.3 Topology Prediction of C. trachomatis MOMP
The results of the above prediction algorithms were combined and adapted to give a
model of the topology of C. trachomatis MOMP (figure 3.2). The two strand predicton
programs between them identified 16 potential p-strands, however the strand inside the
VS1 domain identified only in B2TMPRED was discarded as a possibility, as that region
is considered highly likely to be extracellular. An extra strand was inserted between
L203 and F212 to bring the chain back across the membrane so that all four VS domains
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Figure 3.2: The predicted topology for C. trachomatis MOMP. Cysteine residues
are highlighted in green. Outward facing "aromatic belt" residues are highlighted in
blue. The manually determined transmembrane strand is shaded, and a selection of
periplasmic residues are labelled.
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were orientated to the extracellular side of the membrane. The strand was positioned to
conform to standard observations of transmembrane p-strands, and so that the periplasic
loop was shorter than the extracellular loop.
The final model corresponded well with general construction principles for p-barrels
(Schulz.2000). MOMP is predicted to be a 16-stranded P-barrel, as has generally been
suggested before. The N and C termini join in a strand at the periplasmic barrel end.
The periplasmic turns are short and the extracellular loops long with high sequence
variability. The outer barrel surface largely consists of aliphatic side chains, but towards
the end of the strands there are frequently aromatic residues that form two "aromatic
belts" that contact the nonpolar-polar interface of the bilayer. Twelve charged residues
and numerous polar side chains project into the pore to form the hydrophilic passage
through the bilayer. The external loops contain a high number of charged residues. Of
the nine cysteine residues, six are on extracellular loops, two are on periplasmic turns
and only one is found in a transmembrane strand. The periplasmic cysteines are on
almost opposite sides of the barrel, and would therefore be unable to form an intra¬
molecular disulphide bond, though they could potentially form inter-molecular bonds.
The transmembrane cysteine projects into the barrel pore, and could only be involved in
bonding if loops were to fold into the barrel. Most cysteine residues are on extracellular
loops, where they may interact with each other intra- and inter-molecularly and with
other cysteine-rich surface exposed proteins in the chlamydial outer membrane.
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3.4 Discussion
The combined topology prediction differed in several significant aspects from a
topology prediction that had been made previously for C. muridarum MOMP
(Rodriguez-Maranon et al.2002) based on Diederichs and hyrophobicity plots. Both
concluded that MOMP was a 16 stranded P-barrel, however the prediction presented
here assigned overall slightly longer strands, with an average transmembrane length of
nine amino acids compared to eight. Consequently, the extracellular loops are not so
long. In this study the VS domains have been assigned to loops 2, 4, 6 and 7, compared
to loops 2, 3, 5 and 6 in C. muridarum MOMP. Critically, there were no periplasmic
cysteine residues in the C. muridarum MOMP prediction. In the current model of
chlamydial outer membrane structure, this would prevent important interactions with
OmcB and OmcA, and could also impact subunit oligomerisation. Finally, there are no
proline residues in strands in this C. trachomatis MOMP topology, which have been
shown to be hardly tolerated in [fbarrel transmembrane strands (Koebnik.1999). There
are two strands containing proline in the C. muridarum MOMP prediction.
A hydrophobicity plot was not used as part of this topology predicton as the standard
programs can have problems identifying transmembrane p-strands. While they can
sometimes identify the classic amphipathic strands in porins with alternating hydrophilic
and hydrophobic residues, other strands have different features. The constraint on the
membrane-facing residues on the p-sheet to be hydrophobic is significantly stronger
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than that of the pore-facing residues to be hydrophilic and strands with fewer polar
residues can be misinterpreted. Strand 15 is such an example, with inward-facing
residues of I, T, V and I. The artificial neural network algorithms, however, are trained
on all known porin (3-strands and both TMBETA and B2TMPRED strongly identified
strand 15.
Secondary structure and topology models provide further evidence that MOMP is a 16-
stranded P-barrel porin. The availability of such a model additionally allows more
rational design of experiments to examine the structure and function of MOMP. Due to
the high sequence similarity in other chlamydial MOMPs, especially outside the VS
domains, it is expected that this prediction can also serve as a model for the other
species.
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Chapter 4: Preparation of a series of chlamydial porin constructs
4.1 Mature protein constructs
The first approach to the expression of recombinant MOMP began with expressing the
protein as leaderless constructs that would be directed to inclusion bodies. Several
ompA constructs from different chlamydiae species were made. In each case the gene
was cloned without its leader sequence, to give mature MOMP as the translated product.
A methionine codon was introduced at the 5' end of the sequence to provide a new
transcription initiation site. Genes were cloned into the multiple cloning site of the T7
expression vector pET22b(+) (Novagen), using the Nde I restriction site directly after the
ribosome binding site (figure 4.1). The ATG start codon contained within the Nde I site
is positioned at an optimal distance from the ribosome binding site for transcription
initiation.
A mature Ch. abortus ompA construct in the pET22b(+) vector had been made
previously (Hughes et al.2001) as had mature Ch. pneumoniae ompA. A mature C.
trachomatis ompA (serovar D) construct was available in the pSTBlue-1 cloning vector
(Novagen), but needed modification for use in the expression vector. To achieve this, an
Nde-l restriction site was introduced at the 5' end of the gene by site-directed
mutagenesis (figure 4.2). The same method was used to remove an internal Nde-l site
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T7 promoter lac operator
TTAATACGACTCACTATAGGGGAATTGTGAGCGGATAACAATTCCCCTCTAGAAATAATTTTG





Figure 4.1: The multiple cloning site of expression vector pET22b(+). All
constructs were cloned between either Nde-l and Nco-l, or Nde-1 and BamH I.
The ribosome binding site is also shown (rbs).
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Figure 4.2: Site-directed mutagenesis of C. trachomatis ompA. Overlapping
primers were used to introduce an Nde-I restriction site at the 5' end of the ompA
gene in a pSTBlue-1 vector.
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from the gene. A single thymine to cytosine change (nucleotide 270) resulted in a null
mutation that destroyed the recognition sequence but ensured no change was made to the
primary amino acid sequence. The mutagenised insert was then restricted with Nde-l
and Nco-l to provide a 1,2kbp insert, that was subsequently ligated into the pET22b(+)
vector.
A mature C. muridarum ompA clone was created directly from genomic DNA.
Similarly to the C. trachomatis construct, C. muridarum ompA contained an internal
Nde-l site that required removal before cloning. An equivalent null mutation was
introduced during amplification from the genome using a two step PCR method (figure
4.3). In the first step, ompA was amplified in two parts, 5' and 3' of the mutagenesis site,
each side using a cloning primer and a mutagenesis primer that contained the required
nucleotide substitution. The products of these reactions were used in the second PCR.
The two parts were self-primed for 8 cycles, resulting in a relatively small number of
copies of the entire gene containing the mutation, before being spiked with the two
cloning primers. The major product of this PCR was the full length ompA containing the
mutation. The cloning primers were designed to include Nde-l and BamlA-l restriction
sites, plus enough extra bases to allow subsequent digestion to create sticky ends (New
England Biolabs Inc.2002). The complete C. muridarum ompA gene was then cloned
directly into the pET22b(+) vector.
In addition to the ompA constructs, porB was also cloned. The gene, minus its leader

































Figure 4.3: Schematic of C. muridarum ompA amplification. The gene was amplified
by PCR in two sections, either side of an internal Nde-I restriction site (CATATG), while
introducing a null mutation (PCR1). The products were used to amplify the entire ompA
gene by self-priming then spiking the reaction with the cloning primers (PCR2).
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that was digested to create specific ends and cloned directly into the Nde-l and Nco-l
sites in the pET22b(+) vector (figure 4.4). All constructs were confirmed as correct by
sequencing (MWG Biotech).
4.2 Cysteine mutagenesis
A cysteine-free mutant of C. trachomatis ompA (M9ompA) was made by site-directed
mutagenesis. C. trachomatis ompA contains nine cysteine residues; C26, C29, C33,
C102, CI 15, C182, C184, C207 and C335. Sequential rounds ofmutagenesis were used
to convert all nine to alanine residues in the pSTB-ompA construct before subcloning
into the expression vector as before. Again the correct construct was confirmed by
sequencing.
4.3 Full length constructs
The second approach used to express recombinant MOMP was designed to direct the
protein to the outer membrane of E. coli. This required the inclusion of a signal
sequence, so that the protein would be transported across the inner membrane of the cell.
Signal sequences are cleaved by signal peptidase in the periplasm (Paetzel et al.2000),
following which the protein is folded and inserted into the outer membrane. Full length
C. trachomatis ompA constructs, including either the native chlamydial leader or an E.
coli leader (from the ompT gene), were made by gene extension PCR using the mature
ompA construct as a template (fig 4.5). Each primer in turn was used to amplify the
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porB
Figure 4.4: Amplification ofporB. The porB gene was amplified directly from C.
muridarum genomic DNA and cloned into pET22b(+).
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Figure 4.5: Schematic of full length ompA produced by gene extension. A. The
native chlamydial leader sequence was added to mature trachomatis ompA by three
sequential rounds of PCR, each extending the DNA further upstream. B. An E. coli
leader sequence, from the ompT gene, was added to the mature ompA gene by the
same method.
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ompA gene with a common anti-sense primer containing an Nco-\ restriction site. Three
successive rounds of PCR resulted in the full length gene, including an Nde-l restriction
site at the 5' end. The final product was restricted and cloned into pET22b(+) as
described previously.
The same method was used to create native leader and ompT leader clones of Ch.
abortus ompA and the cysteine-free mutant C. trachomatis M9ompA, and an ompT
version of full length C. muridarum porB, again using the mature constructs as
templates. Native leader clones of C. muridarum ompA and porB were made by direct
amplification from genomic DNA. This was carried out in exactly the same way as for
the mature constructs but using a sense primer positioned to include the signal sequence
in the amplified product.
4.4 Internal mutagenesis of C. trachomatis MOMP
A series of deletion mutant clones were made to investigate the influence of the VS
domains on the structure and function of MOMP. Each of the four VS domains was
removed from the full length C. trachomatis ompA gene using the native chlamydial
leader. Site-directed mutagenesis was used to introduce an identical restriction site, in
frame, at either end of a VS domain, allowing subsequent digestion of the domain from
the gene, before re-ligating the ends back together. The regions of protein removed by
this were: VS1, G63 to Y87; VS2, E141 to F156; VS3, Y220 to G238; VS4, D278 to
T318 (see appendix C). The SDM employed to do this resulted in some slight
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mutations. These were fairly conservative (M62T for VS1, T239V for VS3 and A277V
for VS4) except for the mutation G219D in VS3. However, the topology prediction
places this residue in an external loop, where the extra charge in unlikely to cause
problems. Successful removal of each VS domain was confirmed by hemi-nested PCR
(figure 4.6). The full length gene was amplified with both the cloning primers, to
demonstrate successful subcloning, and with the 5' sense mutagenesis primer and anti-
sense cloning primer. As the 3' half of the mutagenesis primer extends into the VS
domain, successful amplification is only achieved if the domain is still present and
digestion has failed, as in lane 1. The clones in lanes 2-5 are positive for the desired
construct.
4.5 Discussion
A dual approach was taken to express recombinant MOMP for structural and functional
studies. Several different constructs were made of the ompA gene and a second probable
porin, porB, including some with internal mutagenesis. A variety of different molecular
biological methods were used to produce these constructs. The DNA polymerase Pfu
was used throughout for two reasons. Firstly, as a proofreading thermophilic
polymerase Pfu has a low error rate (1.3 x 10"6 errors/nucleotide/cycle) compared to
standard Taq DNA polymerase (8.0 x 10"6 errors/nucleotide/cycle) (Cline et al.1996).
This reduced the likelihood of unwanted mutations being introduced into the DNA
during amplification. All genes were sequenced and confirmed as correct, and it was
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1 23456789 10 11
Figure 4.6: Hemi-nested PCR of C. trachomatis ompA VS2 deletion construct.
1-5: AVS2 clones amplified with VS2 sense and cloning anti-sense primers.
6-10: AVS2 clones amplified with cloning-sense and cloning-anti-sense primers.
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rare for such a secondary mutation have occurred. As a further precaution, all
mutagenised inserts were subcloned into fresh pET22b(+) vector to ensure against
mutations that may have been introduced into other critical parts of the plasmid.
Secondly, Pfu produces blunt ended DNA. This is necessary for the QuikChange site-
directed mutagenesis protocol, so that extra nucleotides are not introduced in the middle
of the gene at the end of each cycle of PCR. Primer design was also important, in
particular for site-directed mutagenesis and gene extension. Mutagenesis primers were
designed to change a maximum of three nucleotides in one round of PCR. Where more
changes were required, for example to create a restriction site, a second pair of
mutagenesis primers was designed to introduce these in a second round of PCR. The
primers included 10-20 nucleotides either side of the mutation to ensure they annealed to
the template despite the central mismatch. With the gene extension primers a balance
had to be achieved between minimising the number of rounds of PCR required to add
the leader sequence, to avoid introducing mutations, yet also avoiding primers of too
great a length. Long primers are more likely to have internal secondary structure that
can make annealing and therefore amplification difficult. Primers approximately 40
nucleotides in length were used, with around 20 nucleotides overlapping with the
template and a further 20 nucleotides being added per round of PCR.
Access to a large range of ompA clones (table 4.1) has several advantages. The two
basic approaches used to express the proteins, combined with the variety of species the
gene was cloned from, serve to increase the chance of producing correctly structured
protein. Additionally, where comparisons are possible between these proteins,
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Table 4.1: Complete series of chlamydial protein constructs: ompA is the gene that
encodes MOMP, porB encodes PorB, oT is the E. coli signal sequence from the ompT
gene, nL is the native chlamydial leader, M9ompA is the cysteine-less mutant of C.
trachomatis and AVS1-4 are the domain deletion constructs.
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information can be obtained relative to structure, function, folding and assembly of
MOMP. The cysteine-free mutant and the internal mutagenesis relating to the VS
domains of C. trachomatis MOMP allow investigation into the roles of these potentially
crucial aspects of the protein. Recombinant C. muridarum MOMP would be useful for
its role in the animal model for C. trachomatis. Finally, the porB construct provides an
alternative target for study where the smaller predicted size, reduced variability of
sequence and potential selectivity are of interest (Kubo et al.2000; Kubo et al.2001).
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Chapter 5: Expression of recombinant chlamydial porins in E. coli
5.1 Mature protein constructs
5.1.1 Porin expression in BL21 cells
The pET22b(+) vector constructs were transformed into BL21(DE3) cells, a standard
expression strain of E. coli with the genotype E. coli B F" dcm ompT hsdS(vu \r\\>~) gal
k(DE3). The DE3 lysogen consists of the T7 RNA polymerase gene under the control of
a lac promoter. On the addition of IPTG the polymerase is expressed, which in turn
transcribes the porin gene. The pET22b(+) vector also contains a copy of the lac
repressor, which inhibits basal protein expression in the absence of IPTG.
In initial expression tests of Ch. abortus MOMP little protein was detected. With
ampicillin resistant vectors loss of plasmid can reduce the efficiency of expression. This
is possible because the ampR product, P-lactamase, is secreted into the culture media
where it can break down all the ampicillin without requiring the antibiotic to enter the
cell. As the P-lactamase builds up in the media, bacteria are able to eject the plasmid
without resulting cell death. The plasmid-free bacteria are not producing the over-
expressed protein and so have a growth advantage over the remaining expressing
bacteria and overtake the culture. Therefore a plasmid stability test was conducted. The
impact on the expression of MOMP was determined by sampling the inducing bacterial
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percentage ampR colonies
2 hours after induction 76 ±8
3 hours after induction 17 ± 11
3 hours after induction
with media change
92 ±6
Table 5.1: Plasmid stability test of Ch. abortus mature MOMP construct.
Percentage of colonies on an ampicillin plate compared to a non-ampicillin plate (±SD,
n=3), relative to an initial ampR of 100%.
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culture at different time points and testing for presence of plasmid (table 5.1). An equal
volume of each sample was spread on agar plates with and without antibiotic, and grown
at 37°C overnight. A comparison of the number of colonies on the different plates
shows the proportion of cells in the original sample that still retained the plasmid.
Plasmid instability was found to be a major determinant of MOMP expression, as only
17% of the bacteria retained ampicillin resistance after three hours of protein expression.
To overcome this, a complete media change was carried out between the bacterial
growth and protein induction. This resulted in an increase of plasmid retention to 92%.
The media change was included in the protocol ofall future expressions.
C. trachomatis MOMP began to express within the first thirty minutes of the addition of
IPTG and continued to accumulate throughout the three hour induction, giving a broad
band at 40kDa (figure 5.1). The band was confirmed as MOMP by western blotting.
5.1.2 Inclusion body (IB) preparation and expression in Aomp8 cells
The recombinant protein comprised a large proportion of the total protein in the cell
lysate. The IBs were thoroughly washed with buffer containing both 1% (v/v) Triton X-
100 and 2M urea (figure 5.2A). This reduced the amount of contaminating proteins but
some remained, most notably a tentative OmpF band. Endogenous E. coli porins in the
sample are difficult to remove completely, and could interfere significantly with later
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Figure 5.1: Expression time course of C. trachomatis MOMP. A. 12% (w/v) SDS-
PAGE stained with coomassie blue. B. Western blot. All samples are protein from
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Figure 5.2: Inclusion body preparation of C. muridarum MOMP. A. MOMP
expressed in standard BL21(DE3) bacteria. B. MOMP expressed in Aomp8 cells. Lane
1 - cell lysate, lane 2 - crude inclusion bodies, lane 3 - washed inclusion bodies. 12%
(w/v) SDS-PAGE, stained with coomassie blue. All samples were boiled for 5mins.
Arrow indicates tentative OmpF band.
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porin-deficient strain of BL21s (Prilipov et al.1998). Aomp8 cells are derived from
standard BL21(DE3) E. coli that have been mutated to give a genotype of BL21(DE3)
AlamB ompF::An5 AompC AompA, with the major porin genes individually knocked
out. MOMP was expressed successfully in these cells, though with a slightly reduced
yield. However the washed inclusion body sample was much purer and free from
contaminant native porin (figure 5.2B).
Protein was recovered from the inclusion bodies by solubilisation in a chaotropic agent
with an excess of DTT (figure 5.3). Urea at concentrations up to 8M was relatively
inefficient, and preferentially solubilised remaining contaminants. In contrast 6M
guanidine hydrochloride was more effective and fully solubilised the recombinant
protein.
5.2 Full length constructs (with leader sequences)
5.2.1 Growth of E. coli expressing leadered MOMP
Full length pET-ompA constructs were also transformed into BL21 cells and expressed
at 37°C. With this expression method, not only must the cells produce the MOMP but it
must also be transported across the inner membrane, the signal sequence digested and
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Figure 5.3: Solubilisation of PorB. Inclusion bodies of PorB, expressed in Aomp8s,
solubilised in increasing concentrations of two chaotropic agents. 10% (w/v) SDS-
PAGE, stained with Coomassie blue.
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Figure 5.4: Growth curves of BL21s expressing full length porins at 37°C. A.
Comparison of C. trachomatis MOMP expressed with native (nL-TR) and E. coli (oT-
TR) leaders and with mature, leaderless MOMP (TR). B. Growth curve of E. coli
during the expression of C. muridarum and Ch. abortus MOMP and PorB with a native
leader (nL-MU, nL-AB and nL-PB respectively) and PorB with an E. coli leader (oT-






a greater strain on the cell than that of mature MOMP expression and so compromise
viability or growth. Therefore a time course of optical densities throughout induction
were measured, allowing the growth curves of the cultures to be plotted (figure 5.4).
Expression of mature, leaderless C. trachomatis MOMP did not measurably inhibit the
growth of the bacteria compared with the cells alone. There is a much greater effect
with expression of full length MOMP. In ompT-MOMP expression the initial growth
rate was comparable to that of the cell only and mature MOMP expression, however the
culture saturated at a lower density. This suggests that whilst expressing the protein
presented no difficulty to the bacteria, the build up of MOMP within the cell increased
the likelihood of cell lysis. During native leadered-MOMP expression the initial growth
rate was inhibited and the saturation density was even lower. Full length constructs of
the other chlamydial genes were variable in their viability (figure 5.4B). Bacteria
expressing C. muridarum MOMP had a slower initial growth rate than those expressing
C. trachomatis MOMP, however the early, low density saturation was not seen and the
culture continued to slowly grow throughout the induction. In contrast, bacteria had
such difficulties with the Ch. abortus MOMP and C. muridarum PorB that there was
barely any initial growth, and the culture density soon began to drop as the cells lysed.
At the end of the induction, no recombinant protein was detected. Selection pressure
was so strong that after only 60-90mins plasmid-free cells began rapidly to take over the
culture, seen in the rapid increase in density in the latter half of the induction. PorB
expression was improved by replacing the native chlamydial leader with the ompT
leader. Initial growth rate was recovered and the decrease in optical density occurred
later in the induction and continued more slowly and for longer before the antibiotic
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selectivity was overcome. No significant difference was seen with Ch. abortus MOMP
when expressed with the ompT leader (not shown). Together, these results indicated that
leadered MOMP expression can slow the rate of cell division, particularly in those
constructs with the native leader sequence. For C. trachomatis MOMP and PorB this
was improved by substituting the native leader with the ompT leader. For most
constructs a second problem, of cell death as the recombinant protein increased in the
cell, resulted in a suppressed density of culture saturation.
5.2.2 Optimisation of expression in Aomp8 cells
It was desirable to express the full length constructs in Aomp8 cells, as contaminant E.
coli porins would be particularly likely to interfere with subsequent work in this
expression system. However, problems with cell death were even more pronounced in
this cell strain than in standard BL21 cells. The expression conditions were therefore
optimised to give the best possible yield of protein. Inductions were carried out on both
native and ompT leadered C. trachomatis MOMP, rapidly at 37°C with ImM IPTG and
slowly at 16°C with O.lmM IPTG (figure 5.5A). Both versions of MOMP were
expressed strongly at 37°C with about half of the protein being processed, as evidenced
by the doublet band ofMOMP with and without the signal sequence (~2kDa difference).
When native-MOMP was expressed at 16°C there was a slight decrease in total protein
but the proportion of protein that was processed was unchanged. There was a larger
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Figure 5.5: Optimisation of expression of full length C. trachomatis MOMP. A.
Outer membranes from 0.5ml of AompB cells (08) with native and ompT MOMP
expressed at 37°C and 16°C in LB medium. Upper arrow indicates full length MOMP,
lower arrow indicates processed, mature MOMP. 12% (w/v) SDS-PAGE, stained with
Coomassie blue. B. Growth curve of oT-TR expressed in LB and SOC media at 16°C
in Aomp8 cells. C. oT-TR MOMP expressed in Aomp8 cells grown in LB and SOC,
and extracted from the outer membrane in 1% (w/v) OG. Protein from 0.75ml cells.
Western blot.
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of it was processed to the mature form. Induction was also carried out in different
growth media to try to further improve protein yield. "Slow" expression of ompT-
MOMP was carried out in both LB and SOC media (figure 5.5B). The cultures grew at
a similar rate for the first 6 hours of induction, at which point the LB culture levelled off
at OD6oo -0.85, after which the cells began to lyse and the density to fall. In contrast,
the SOC culture continued to grow and remained unsaturated twelve hours after
induction. As expected, the yield of MOMP was increased in the SOC culture (figure
5.5C).
5.3 Discussion
An important consideration when expressing chlamydial porin constructs in E. coli has
been to overcome problems associated with the toxicity of the recombinant protein to the
bacteria. The pET vectors are T7 lac based and pET22b(+) has in addition an extra layer
of restriction on basal (non-induced) protein production by having the lac repressor
encoded on the plasmid. This is a very tightly controlled system, yet plasmid instability
was still a problem. However, it was found that the incorporation of a complete media
change into the protocol was largely able to prevent this. Using a kanamycin resistant
instead of an ampicillin resistant plasmid at the outset would have provided a surer way
of preventing plasmid loss, however the Aomp8 cells have chromosomal kanamycin
resistance, so unfortunately that was not possible.
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The expression of full length protein was particularly problematic, as the same toxicity
and plasmid instability issues were compounded by the problem of cell lysis as the
amount of processed protein increased. The level of lysis varied greatly between
constructs. Expression of Ch. abortus MOMP and C. muridarum PorB were rapidly
fatal to the bacteria, as indicated by the finding that antibiotic selectivity was overcome
after only ~1 hour of induction. The effect was such that no recombinant protein was
detectable at the end of the 3 hour expression (not shown). C. trachomatis MOMP was
relatively non-toxic to the cells, and in bacteria expressing C. muridarum MOMP cell
lysis did not overtake growth at any point in the induction. In some cases substituting
the chlamydial leader sequence for a leader from an E. coli outer membrane protein -
OmpT - reduced cell lysis, and improved cell survival is the likely cause of the larger
yield of recombinant protein seen in the oT-TR versus nL-TR outer membrane
preparations (figure 5.5A).
It is probable that as a result of all the absent porins Aomp8 cells have a much less stable
outer membrane than unmodified BL21 cells. This is reflected in a generally higher
tendency towards lysis. It is perhaps unsurprising that the overproduction of a protein
that can effectively create holes in the outer membrane can be fatal to the cell. For this
reason SOC medium was explored as an alternative growth medium. SOC medium is
typically used in the transformation of bacteria with DNA. The exact mechanism of
transformation is poorly understood, but it does involve permeablisation of the
membrane to allow entry of the DNA. The conditions in SOC medium are such that this
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is less likely to result in cell death. It was considered that the expression of recombinant
porin in Aomp8 cells might be analogous to the situation involved in transformation.
This seems to have been borne out in the dramatic improvement in cell survival when
grown in SOC compared to LB, without any difference in the initial growth rate between
the two cultures.
Recombinant MOMP and PorB have been successfully expressed by both approaches.
All the constructs expressed well in the mature form to inclusion bodies, with yields of
80-150mg protein per litre culture. Protein in the cleaned and solubilised inclusion
bodies had a high level of purity and was suitable for future in vitro refolding
experiments. There was, however, more variability with the full length MOMP
approach to expression, and it was not possible to express Ch. abortus in a form that
could be processed to the outer membrane at all. Of the proteins tested, C. trachomatis
and C. muridarum MOMP showed best expression, using ompT and native leaders
respectively. C. trachomatis ompT-MOMP was expressed optimally in Aomp8 cells in
SOC medium containing O.lmM IPTG at 16°C. As problems of the translocation and
processing of large quantities of recombinant protein, and of Aomp8 cell lysis apply to
all constructs, this optimisation is likely to generally improve expression. At this stage
the fully processed proteins can be extracted from the outer membrane using detergents,
for further analysis and purification.
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Chapter 6: Characterisation of outer membrane expressed MOMP
6.1 Surface expression of MOMP
MOMP was successfully expressed in BL21 and Aomp8 cells with leader sequences and
translocated to the periplasm. The signal sequence was digested to give the mature
form, which was isolated as part of the membrane fraction of the cell. However, MOMP
could be merely associated with the membrane peripherally, rather than fully inserted
into the outer membrane as an integral membrane protein. To examine whether the
protein had truly inserted into the outer membrane, whole cell immunoblots were used to
test for the presence ofMOMP on the surface of expressing cells.
BL21 cells and BL21s transformed with mature, leaderless C. trachomatis MOMP (TR),
ompT-MOMP (oT-TR) and native leadered-MOMP (nL-TR) were induced for 2 hours
at 25°C. Intact cells were harvested by a short and slow centrifugation, and resuspended
in PBS pH 7.4. A sample of each was spotted and dried onto nitrocellulose membrane.
Nitrocellulose was used as no methanol was needed at any stage. Methanol could have
permeablised the outer membrane and distorted the results. MOMP was detected using
the anti-C. trachomatis MOMP polyclonal antibody. No non-specific binding was
picked up on the BL21 cell only control (figure 6.1). Additionally there was no binding
to MOMP expressed in the mature form, indicating the drying and blotting protocol did
not cause cell lysis. Both the ompT and native leadered MOMP were detected, ompT-
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BL TR oT-TR nL-TR
• AV9P
Figure 6.1: Whole cell immunoblot of leadered C. trachomatis MOMP. BL21 cells,
and BL21s expressing mature C. trachomatis MOMP and ompT and native leadered
MOMP dried on to nitrocellulose membrane. Surface-exposed MOMP detected by
blotting with anti-C. trachomatis MOMP polyclonal antibody.
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MOMP in greater amounts. This demonstrated that in both cases the protein was
successfully inserted into the outer membrane. It is unlikely that this could have
happened without some folding of the protein. Interestingly, with equivalent
immunoblots for MOMP expressed at 37°C, no protein was detected on the cell surface,
although translocated and processed protein was found in the membrane fraction.
Unfortunately, it proved impossible to repeat these experiments in Aomp8 cells, as these
more fragile bacteria lysed during the protocol so that results could not be conclusive.
The effect of internal mutagenesis of C. trachomatis MOMP on membrane insertion was
examined (figure 6.2). Cysteine-less MOMP, M9-MOMP, was unaffected by the
mutagenesis and was detected on the cell surface of bacteria expressing both the ompT
and native leadered versions. This suggests that disulphide bonds are not essential for
folding and membrane insertion. The importance of the VS domains was also examined.
Four native leadered C. trachomatis MOMPs, each lacking one of the VS domains, were
expressed and the cells blotted. In each case MOMP was detected on the cell surface,
indicating the VS domains are extracellular loops as predicted, rather than
transmembrane p-strands and are also, at least individually, not essential for folding and
insertion into the outer membrane. The variable intensity of signal from the mutant
constructs could be as a result of differences in the rate of membrane insertion,
differences between populations of the polyclonal antibody that react to the missing
regions, or some combination of both.
75
A
BL M9 oT-M9 nL-M9
p
BL TR nLTR AVS1 AVS2 AVS3 AVS4
Figure 6.2: Internal mutagenesis of C. trachomatis MOMP. A. Whole cell
immunoblots of the cysteine-less (M9-MOMP) constructs; cell only, mature M9-
MOMP, ompT leadered M9-MOMP and native leadered M9-MOMP. Surface-exposed
MOMP detected by blotting with anti-C. trachomatis MOMP polyclonal antibody. B.
Whole cell immunoblots of VS domain deletion constructs, all expressed with the native
leader sequence. Surface-exposed MOMP detected by blotting with anti-C. trachomatis
MOMP polyclonal antibody.
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6.2 Oliqomerisation in the outer membrane
Chlamydial MOMPs are predicted to be trimeric porins, as MOMP purified from the
chlamydial membrane ran as SDS-resistant putative trimers on electrophoresis (Wyllie
et al.l 998). However, in the chlamydial membrane MOMP is part of an extensive
network of cross-linked proteins, which combined with the difficulties in purifying large
quantities of MOMP has made it difficult to examine its intra- and inter-subunit
interactions in isolation from other cysteine-rich chlamydial outer membrane proteins.
The oligomeric state of MOMP expressed in E. coli membranes was therefore
investigated.
Outer membranes were prepared from Aomp8 cells expressing C. trachomatis MOMP,
grown in SOC medium and induced at 16°C. Samples were incubated in SDS loading
buffer with or without reducing agent at room temperature for lOmins. Proteins were
separated by SDS-PAGE and detected by immunoblotting (figure 6.3). Fully reduced
MOMP ran as a broad single band at 40kDa but oxidised MOMP, incubated without
reducing agent, ran as a smear. Several stronger, distinct bands were, however, detected
within the smear. Denatured, monomeric MOMP runs as a band at 40kDa (DM) as in
the reduced sample. Another strong band at ~35kDa is also likely to be monomeric
MOMP, but folded and running ahead of its molecular weight as has been seen with














Figure 6.3: The role of disulphide bonds in MOMP oligomerisation. C. trachomatis
MOMP outer membrane protein separated by SDS-PAGE with (RED) and without (OX)
reducing agent in the sample, and cysteine-free M9-MOMP without reducing agent.
Western blot from the gel. Predicted denatured monomer (DM), monomer (1), dimer (2)
and trimer (3) bands, and putative tetramer band.
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higher molecular weight that would correspond to dimers and trimers (~80kDa,
120kDa). Above this size the molecular weights of bands are difficult to determine
accurately, however, the band below the 250kDa marker could plausibly be a tetramer
with other higher order complexes seen at the top of the gel.
The presence of a folded monomer band in the oxidised but not the reduced sample
indicated that at least one intra-molecular disulphide bond was involved in the structure
of MOMP. The ability of the cysteine-less mutant to be expressed and inserted into the
outer membrane suggests that this disulphide bond is likely to be involved in the
stabilisation of the tertiary structure, so that the protein is SDS-resistant, rather than
essential for the folding itself. MOMP was also present in the outer membrane in a
variety of oligomeric forms, with two, three or more monomers associated together. It is
unclear whether the subunits are connected by disulphide bonds, as the destabilisation of
the monomer subunits by reduction could result in subunit dissociation even if cysteine
residues were not involved.
6.3 Size exclusion chromatography
Protein from the outer membrane was solubilised in 1% (w/v) Zwittergent 3,14 and
lOmM DTT, then separated by size exclusion chromatography in 0.05% (w/v)
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Figure 6.4: Size exclusion chromatography of C. trachomatis MOMP. A.
Separation of zwittergent 3,14-solubilised MOMP, with dot blots of collected 5ml
fractions. B. Calibration of column in the presence of zwittergent 3,14. Standards were
apoferritin, pyruvate kinase, lactate dehydrogenase, bovine serum albumin, ovalbumin.
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PVDF membrane and fractions containing MOMP were detected by immunoblotting.
MOMP eluted in two peaks. A large proportion of the protein eluted in a broad peak
with the void volume, with a slow tail off over the next 50ml. A significant fraction of
the protein eluted in a second peak, with its maximum at a volume of 177ml. The
column had been calibrated in the same buffering conditions (figure 6.4B), including
detergent, and the peak was calculated to correspond to 125kDa. This indicated a
portion of the MOMP in the sample was in trimeric form.
The experiment was repeated using protein solubilised in 1% (w/v) LDAO and DTT,
then separated by chromatography as before but with 0.05% (w/v) LDAO as the
detergent in the buffer (figure 6.5A). MOMP again eluted in two sections. A much
larger proportion of MOMP eluted with the void volume than with Zwittergent 3,14-
solubilised MOMP. The correspondingly small amount of MOMP that eluted later was
not enough to create a visible peak on the trace against background protein, however the
dot blots showed a peak with a maximum at 193ml or 78kDa. Although most of the
MOMP in this LDAO sample existed as very large complexes or aggregates, some was
eluting as a dimer. C. trachomatis M9-MOMP was also expressed and extracted in
Zwittergent 3,14. On separation by size exclusion chromatography, M9-MOMP eluted
more evenly than wild type MOMP (figure 6.5B). The peak at the void volume was
lower and broader, and M9-MOMP continued to be detected in each fraction over the
next 80ml. However, a second maximum could be seen both in the A280 trace and in the
















Figure 6.5: Size exclusion chromatography of C. trachomatis MOMP and M9-MOMP.
A. Separation of LDAO-solubilised MOMP with dot blots of collected 5ml fractions. B.
Separation of Zwittergent 3,14-solubilised M9-MOMP with dot blots of collected 5ml
fractions.
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that the oligomerisation of MOMP is highly condition dependent. The difference
between MOMP and M9-MOMP extracted in Zwittergent 3,14 indicates that disulphide
bonds have some role in this. Although the MOMP sample was in sufficient DTT
concentrations to fully reduce all the cysteine residues, not all were necessarily solvent
accessible. This could account for the larger proportion of very high molecular weight
protein eluting with the void volume compared to cysteine-less MOMP. However,
disulphide bonds are not the only factor in oligomerisation, as seen with the distinct
difference between MOMP solubilised in two alternative detergents, and that M9-
MOMP did not elute as monomers. In these circumstances it is difficult to define the
true multimeric state ofMOMP.
6.4 Planar lipid bilayer analysis of C. trachomatis MOMP
In addition to examining the structure of recombinant MOMP it was important to
consider function. To this end, chromatography purified MOMP was reconstituted into
planar lipid bilayers. Aomp8 cells containing empty vector were grown and expressed,
and the outer membranes extracted and purified by chromatography. Fractions matching
the volumes where MOMP had eluted were retained. These were added to the cis
chamber of the bilayer setup. In six independent attempts, no channels incorporated into
the bilayer from these controls. Additionally, no channels were obtained when MOMP
samples from the first peak at the void volume were added. This was perhaps
unsurprising, as the protein there was likely to be misfolded aggregate or in complexes
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simply too large to enter the bilayer. However, when MOMP from the second peak was
used, channels were incorporated. On the addition ofMOMP in Zwittergent 3,14, porin-
like unit conductances were observed in the bilayer (figure 6.6). With the cis chamber
voltage clamped at +40mV, the gating was frequent, however as the voltage was
increased the channels spent more time closed. The bilayer also became less stable,
though the channel openings were still clearly distinguishable. MOMP in LDAO gave
very similar channels. Overall, the conductance of the channels was 0.46 ± 0.07nS in
500:500mM KC1 (± SD, n=7). This value would be appropriate for a porin, and is
consistent with data from Ch. abortus MOMP (Wyllie et al.1998).
6.5 Discussion
Previous attempts to express MOMP recombinantly have shown that association with
the outer membrane is not sufficient to demonstrate the full insertion of porin into the
membrane. While the surface exposure of MOMP does not prove it to have a fully
stable, native structure, it does indicate that folding is well advanced. Investigations into
the in vivo folding pathways of other porins suggest that full insertion into the membrane
is a relatively late step in the process (Jansen et al.2000). When performing the whole
cell immunoblots to test for surface exposure, keeping the bacterial membrane intact
during the experiment was of primary importance. Cells were taken from the inducing
culture before saturation so that most cells would be intact. The bacteria were then
washed gently in PBS to remove any lysed cells or MOMP that had been released into
the medium. As PVDF membranes must be pre-activated in methanol, nitrocellulose
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Figure 6.6: C. trachomatis MOMP reconstituted into planar lipid bilayers.
Recordings made in symmetrical 500mM KC1, 2mM DTT. Downward currents
represent channel openings. A. Voltage-clamped at +40mV. B. Voltage-clamped at
-MOOmV.
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membranes were used in these experiments, to ensure no lingering methanol could
permeablise the outer membrane to antibody. Finally, a control for cell lysis during the
protocol was provided, in the form of BL21 cells expressing the mature versions of the
constructs. Deliberate lysis of these control cells resulted in a positive signal on the
immunoblot (not shown). Unfortunately the Aomp8 cells could not be used in these
experiments as the more fragile membrane meant that they did not survive the protocol
without rupturing. However, as MOMP produced in Aomp8 cells has in all other aspects
displayed the same characteristics as that produced in standard BL21s, it is likely to also
be surface exposed. The signal from cells expressing oT-TR was stronger than the nL-
TR in both wild type and M9-MOMP. This is most likely due to the previously
demonstrated better processing of protein with the E. coli leader compared to the
chlamydial leader, resulting in a larger quantity ofmature MOMP available for folding
and membrane insertion. Of particular interest is that immunoblots consistently failed
when the bacteria were grown at 37°C, although processed, mature MOMP is present at
this temperature. This suggests that, although the cell can translocate and digest MOMP
efficiently at the higher temperature, at some point in the folding/insertion pathway the
process breaks down and the protein accumulates in the periplasm. This could be where
previous attempts to express MOMP in this way have failed. Membrane-bound
intermediates in the E. coli porin OmpA folding pathway have also been shown to be
stabilised at lower temperatures (Kleinschmidt et all996). The lower temperature of
expression in the method presented here could slow the periplasmic aggregation of
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MOMP, and help stabilise folding intermediates, sufficiently to allow a portion of the
protein to complete the folding pathway and insert into the membrane.
The oligomerisation of MOMP is complex. When outer membranes were solubilised
directly into SDS-loading buffer without prior reduction, several bands were seen,
corresponding to multiples of one, two, three and more subunits of MOMP. When
reduced, a strong, denatured monomeric band at 40kDa was observed. The same result
is shown when C. trachomatis chlamydial EBs are solubilised directly into SDS-loading
buffer (Newhall et al.1983), indicating MOMP in the E. coli outer membrane is in a
similar environment as in the extracellular form of the native bacteria. MOMP
solubilised from Ch. abortus in the detergent octyl-P-D-glucopyranoside or non-
denaturing concentrations of SDS runs on SDS-PAGE as an SDS-resistant lOOkDa
oligomer, in the presence of DTT (Wyllie et al.l 998). Here, a portion of Zwittergent
3,14-solubilised MOMP has been shown to elute from size exclusion chromatography in
DTT at the approximate molecular weight of a trimer. This oligomeric protein was not
SDS-resistant. Changing the detergent to LDAO resulted in a change of elution pattern,
where the non-complexed MOMP eluted with the molecular weight of a dimer.
Despite the presence of sufficient DTT in these experiments to fully reduce all
disulphide bonds, the cysteine residues are still involved in the structure, as seen by the
differences between elution patterns ofwild type and M9-MOMP. There is less protein
in the early void volume peak with M9-MOMP. This very high molecular weight peak
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is probably composed of two distinct populations of MOMP. Some may be misfolded
protein that did not complete the folding and membrane insertion pathway and instead
aggregated in the periplasm, as has been seen with other attempts at producing
recombinant MOMP in this way. This would be the case for M9-MOMP as well as for
the wild type protein. The second population may be of highly disulphide bonded
oligomers of MOMP in the outer membrane. There would be none of this group in the
M9-MOMP sample, explaining the decreased void volume peak. Although the non-
complexed M9-MOMP peaks to a maximum at the molecular weight of a tetramer, the
pattern is less well defined than for wild type MOMP with protein detectable across a
wide range.
It seems clear that the quaternary structure of MOMP is highly condition dependent,
both in terms of lipid and/or detergent environment and in the redox state of the cysteine
residues. The latter is related to the former by solvent accessibility for reducing agents.
The dimeric and trimeric MOMP obtained here have not been SDS-resistant when
reduced. This could be attributable to differences between the Ch. abortus MOMP that
previously demonstrated possible trimers, and the C. trachomatis MOMP used here.
The oligomers of C. trachomatis MOMP observed in EBs were not SDS-resistant when
reduced (Hackstadt et al.l 985). Repeat experiments need to be extended across a range
of species so that data from different MOMPs can be combined and compared
effectively. Alternatively, MOMP as a defined trimer may be purely artifactual. It has
been shown here that simply changing the solubilising detergent can affect the number
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of subunits associating. This raises concerns that detergent solubilised MOMP may not
be a true reflection of its situation in vivo.
Importantly, recombinant MOMP produced here has been shown to form porin-like
channels in a planar lipid bilayer, comparable in size to native MOMP. More analysis,
in particular on the effect of redox potential, is needed to fully characterise the channels
and interpret their other properties.
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Chapter 7: In vitro refolding of chlamydial outer membrane proteins
7.1 Investigation of refolding conditions
Initial attempts at refolding MOMP from guanidine solubilised inclusion bodies were
made according to protocols developed for other porins (Minetti et al.1997; Jansen et
al.2000), without success (not shown). A screening process was therefore employed to
establish folding conditions empirically, using the Foldlt Protein Folding Kit (Flampton
Research). As MOMP has no enzymatic activity some other form of assay was required
to measure success. Using a lipid bilayer or vesicle based assay to test for channel
function was inappropriate, as the lipidic environment of the protein in these systems
could have either an enhancing or deleterious effect on the folding of the protein that
may be unrelated to the initial folding conditions. However, misfolded proteins tend to
aggregate and precipitate from solution, and this can be easily measured with a visible
spectrometer. Initial screens were carried out with 0.1% (w/v) LDAO and 2mM DTT
added to all Foldlt reagent combinations and diluting denatured MOMP into the
solutions. These screens were assessed by measuring the absorbance of the solutions at
400nm, with high absorption indicating marked precipitation and low absorption
showing that the protein remained in solution. A comparison of the absorbance readings
with different reagents provides a numerical analysis of the tendency of each reagent to
promote or inhibit misfolding and aggregation of the protein.
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Numerous conditions were investigated using this screen; including pH, protein
concentration, salt concentration, the presence of an osmolyte (PEG 3350), a chaotrope
(GuHCl), the addition of cations (Ca2+ and Mg2+) or chelator (EDTA) and the presence
of nonpolar (sucrose) and polar (arginine) additives (see appendix D.l for
combinations). The absorptions of all the samples containing each individual reagent
(eg. GuHCl) were added together, then presented as a proportion of the total absorption
of all the samples (table 7.1, see appendix D.2 for original readings). As each reagent
was present in half of the screening combinations, a reagent that had no effect on folding
should have a relative total absorbance of 0.5. Values >0.5 show a tendency to increase
misfolding and aggregation, while values <0.5 show a tendency to inhibit them. The
further from 0.5 the value is, the larger the impact on folding. Some conditions stood
out in particular. C. muridarum MOMP showed a strong preference for pH 8.2, low
protein concentration and the presence of a chaotropic agent in its refolding buffer.
Milder preferences were seen for low salt concentration, and the presence of a chelating
agent and a polar additive. Similar results were seen when the cysteine-less C.
trachomatis M9-MOMP was screened, though with generally milder preferences:
perhaps a reflection of a decreased tendency towards aggregation without any possibility
of disulphide bond formation. The screen was repeated by dialysis instead of dilution,
but the protein always showed higher absorption at 400nm than that observed in the
equivalent dilution, so that method was not pursued. These basic conditions were used





pH 8.2 0.06 0.07
pH 6.5 0.94 0.93
low [protein] 0.12 0.34
high [protein] 0.88 0.66
high NaCI 0.59 0.57
low NaCI 0.41 0.43
+ osmolyte 0.54 0.58
- osmolyte 0.46 0.42
+ chaotrope 0.13 0.34
- chaotrope 0.87 0.66
cation 0.57 0.55
chelator 0.43 0.45
+ nonpolar 0.51 0.48
- nonpolar 0.49 0.52
+ polar additive 0.42 0.45
- polar additive 0.58 0.55
Table 7.1: Foldlt screen of refolding from denatured C. muridarum MOMP (MP)
and C. trachomatis M9-MOMP. MOMP diluted into Foldlt screening reagents were
mixed overnight at 4°C. The absorbances at 400nm were measured and added for each
condition. Data are presented relative to the total absorbance of all samples.
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7.2 Circular dichroism (CD) analysis of refolding conditions
While lack of aggregation was a useful assay for the rapid elimination of incorrectly
folded samples in the initial screens, a more positive assay was required for further
analysis of refolding. Circular dichroism is a spectroscopic technique that measures the
difference in absorption of left and right circularly polarised radiation by chiral
molecules. Proteins are inherently so due to the chirality of all the composite amino
acids, except glycine. The far UV region corresponds to absorption by peptide bonds
and analysis of the CD spectrum of proteins can determine the content of regular
secondary structural features (Kelly et al.2000). For example, a-helical structure
displays characteristic double minima at 208 and 222nm, whereas p-sheet structure
shows a single minimum at 217nm and has a mean residue ellipticity of zero at a longer
wavelength than a-helix (figure 7.1). Native MOMP was shown to have similar
secondary structure to other, known porins in CD analysis (Wyllie et al.1998) therefore
the technique was adopted as an assay to examine the refolding ofMOMP.
C. trachomatis M9-MOMP was diluted to approximately 0.5mg/ml into refolding
buffers containing the reagents suggested by the above screening (50mM Tris-HCl pH
8.2, ImM EDTA, lOmM NaCl, 500mM GuHCl, 500mM L-Arginine) plus various
detergents at concentrations of 1, 10 and 50 times the critical micelle concentration
(CMC). The refolding mixtures were incubated overnight at 4°C with stirring. All
samples containing the detergent zwittergent 3,14 and n-octyl-P-D-glucopyranoside
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Figure 7.1: Far UV CD spectra of various secondary structures. Solid line shows
a-helix, long dashes anti-parallel p-sheet, dots type I P-turn and dots and dashes
irregular structure. From Kelly and Price (2000).
94
completely precipitated at this stage. Where the protein was still in solution and the
absorbance at 400nm measured <0.05, the sample was dialysed with two changes to
remove the guanidine and arginine, and to reduce the detergent concentration to just
above the CMC so the background detergent absorption was minimal for the CD
analysis. The sample was then dialysed with two changes into CD buffer, containing
50mM sodium phosphate pH 8.0 and just above one times the CMC of the appropriate
detergent. CD spectra were measured (figure 7.2A,B,D and E) and the results analysed
using the CONTINLL, SELCON3 and CDSSTR programs. The results of all three
programs were similar, therefore only those from CDSSTR are shown (figure 7.2C and
F). MOMP diluted into the non-ionic detergents n-decyl-p-D-maltopyranoside (DM)
and n-dodecyl-P-D-maltopyranoside (DDM) showed spectra indicative of a large portion
of a-helical structure. This could be seen in the distinctive minima at 208nm and in the
trace crossing the axis below 200nm wavelength. This was borne out in the computer
analysis, with more than a third of the overall structure assigned to a-helix, generally
more than was assigned to P-structure. MOMP diluted into LDAO also showed a
spectrum characteristic of significant helical structure. On analysis the proportion of
structure assigned to a-helix was less than with DM and DDM, however this was
balanced by an increase in irregular structure. Higher concentrations of LDAO
increased the proportion of irregular structure in the protein further. Finally, MOMP
was diluted into refolding buffer containing Cymal-6. The spectra showed less
pronounced helical features, with higher concentrations of detergent showing strong P-
structure content. The ellipticity at 208nm was increased with increasing detergent, and
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DM a p irregular DDM a p irregular
1 x CMC 38% 35% 27% 1 x CMC 36% 31% 33%
10 x CMC 38% 31% 31% 10 x CMC 45% 36% 18%
50 x CMC 40% 37% 25% 50 x CMC 34% 36% 30%
Figure 7.2: Circular dichroism analysis of C. trachomatis M9-MOMP refolding in
various detergent environments. A. CD spectra of MOMP refolded in different
concentrations of DM. B. In DDM. C. CDSSTR analysis of secondary structure




LDAO a B irregular CYMAL-6 a B irregular
1 x CMC 30% 35% 36% 1 x CMC 23% 38% 40%
10 x CMC 31% 31% 39% 10 x CMC 22% 42% 37%
50 x CMC 24% 29% 47% 50 x CMC 17% 47% 34%
Figure 7.2: Circular dichroism analysis of C. trachomatis M9-MOIV1P refolding in
various detergent environment (cont). D. CD spectra of MOMP refolding in
different concentrations of LDAO. E. In Cymal-6. F. CDSSTR analysis of secondary
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in the 50 times CMC sample the minimum was at the 217nm associated with (3-sheet.
The computer analysis agreed, with less a- and more (3-structural content as the Cymal-6
was increased. The effect of redox on secondary structure and folding was examined
using C. muridarum MOMP, which contains 8 cysteine residues. MOMP was diluted
into refolding buffers as before containing 1 x CMC LDAO and different redox
conditions. Similarly to the M9-MOMP, C. muridarum MOMP with 2mM DTT showed
a spectrum with the 208nm minimum, and analysis assigned the largest portion of the
protein structure as irregular (figure 7.3). Refolding buffer containing lmM:0.1mM
reduced (GSH) to oxidised (GSSG) glutathionine showed only slightly improved
structural assignments. However when the ratio was decreased to ImM GSH:0.2mM
GSSG there was a large change in both the CD spectrum and the computer analysis.
The ellipticity at 208nm was greatly reduced, with the minimum now at the (3-sheet
indicative 217nm. This was accompanied by a shift to the right where the spectrum
crosses the x-axis, to greater than 200nm, again a sign of increasing (3-content. The
analysis assigned only 7% of the structure to a-helical and 59% to P-structural content.
7.3 Refolded C. muridarum MOMP
The various conditions identified as inhibiting aggregation and promoting P-structure
formation were combined and used to refold C. muridarum MOMP. MOMP was diluted
dropwise 1:50 into refolding buffer containing Tris-HCl pH 8, EDTA, NaCl, GuHCl and







DTT 24% 34% 43%
1mM GSH, 0.1mM GSSG 20% 40% 40%
1mM GSH, 0.2mM GSSG 7% 59% 33%
Figure 7.3. The effect of redox conditions on secondary structure. C. muridarum
MOMP diluted into 1 x CMC LDAO refolding buffer containing either 2mM DTT or
ImM reduced glutathionine with 0.1 or 0.2mM oxidised glutathionine.
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This refolding mix was incubated at 4°C overnight with gentle stirring. The protein was
then dialysed against refolding buffer without GuHCl or arginine and with only 0.03%
(w/v) Cymal-6 Oust over the CMC). A portion of the sample was further dialysed into
an appropriate CD buffer and the absorbance measured. The spectrum was strongly
characteristic of anti-parallel p-sheet (figure 7.4). The computer analysis assigned 65%
of the secondary structure as P-structure, with only 6% a-helical. The remaining 29%
was irregular structure. These values are similar to that obtained from native Ch.
abortus MOMP (Wyllie et al.1998).
While the correct formation of secondary structure is critical to folding, it does not
necessarily prove the final tertiary fold has been made. Therefore the refolded MOMP
was further characterised. When separated by non-reducing SDS-PAGE, MOMP ran as
a very high molecular weight band that barely entered the separating gel, but fell apart
into denatured monomers upon incubaton with reducing agent (not shown). Protease
resistance is another indicator ofporin P-barrel formation. MOMP briefly digested with
proteinase K then separated by non-reducing SDS-PAGE ran as a heat modifiable, SDS-
resistant trimer (figure 7.5). The trimer denatured between 65 and 70°C, a temperature
similar to that seen with other trimeric porins. The proteinase K-treated MOMP also
dissociated into denatured monomers in the presence of reducing agent. Taken together,
these results indicate that MOMP has refolded into a high order complex of MOMP
subunits composed of stable trimers. The stability of both the trimer and the larger
complex is dependent on disulphide bond formation.
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Figure 7.4: CD spectrum of refolded C. muridarum MOMP. MOMP in 50mM
sodium phosphate, pH 8, 0.03% cymal-6, ImM GSH and 0.2mM GSSG. Secondary
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Figure 7.5: Thermostability of refolded C. muridarum MOMP. Proteinase K-treated
MOMP samples were incubated at each temperature for 10min.l0% (w/v)
polyacrylamide, non-reducing SDS-PAGE. Stained with GelCode colloidal blue stain.
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7.4 Discussion
The process of in vitro refolding of proteins from inclusion bodies is poorly understood
and can be difficult to achieve, particularly with membrane proteins. As with
crystallisation, even slight changes in sequence can affect the conditions required for
success. Amongst porins, despite the strong structural similarity, there is very little
sequence homology and it was perhaps unsurprising that protocols used for other porins
did not work with MOMP. Establishing refolding conditions empirically can be very
time-consuming due the huge range of combinations possible. Using the Foldlt screen
together with spectroscopic measurement allowed the rapid optimisation ofmany of the
basic conditions without wasting time or resources. The smaller range of combinations
could then be analysed further by methods that give more information about the
structural state of the protein. CD analysis was a useful tool at this stage. It is still
relatively quick and easy to do yet can give useful information on the progress of protein
folding. Unlike the standard spectroscopic measurement, CD can distinguish
intermediate levels of folding at secondary structural level, allowing the rational
optimisation of conditions. These two levels of screening suggested a set of conditions
most favourable to the correct folding ofMOMP.
The refolded MOMP showed characteristics that suggested the folding was correct. The
secondary structure was comparable to that of native MOMP from Ch. abortus.
Although no CD analysis of native C. muridarum was available, it is likely to be very
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close to that of other species. C. muridarum and Ch. abortus share 62% sequence
identity and much of the differences are concentrated in the VS domains that, as
extracellular loops, probably are within the irregular portion of the secondary structure.
In any case, both the native and recombinant MOMPs exhibit secondary structure
characteristic of other known porins. Although MOMP ran as a very large molecular
weight band on non-reducing SDS-PAGE there is evidence to suggest this was not just a
misfolded aggregate. During initial screening MOMP readily precipitated when
misfolded, and when these samples were separated by SDS-PAGE, the aggregate did not
enter the gel and was unaffected by reducing agent (not shown). In contrast the refolded
MOMP always remained soluble and disassociated into denatured monomer in the
presence of reducing agent. On digestion with proteinase K, the large complex runs as a
porin-like trimer, that is highly stable, SDS and heat resistant when oxidised. Although
more analysis is required, these results suggest that MOMP has refolded correctly into
p-barrels that form disulphide-mediated stable trimers. Further disulphide bond
formation results in the oligomerisation of the trimers into higher order complexes of
MOMP that may in fact be more truly representative of the in vivo state of MOMP than
the smaller trimers shown.
Unfortunately it has not been possible to obtain planar lipid bilayer recordings of this in
vitro refolded MOMP. The higher order complexes are simply too large to insert into
the bilayer and trimers produced by proteinase K treatment only resulted in unstable,
flickering openings without well-defined unit openings. It is possible that the protease
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treatment caused some nicks to be made in the loops of the protein that allowed the
breaking apart of the large complexes, but also adversely affected protein function.
Establishing an effective in vitro refolding method for recombinant MOMP would make
a valuable contribution to chlamydial research. The main advantage of MOMP
produced this way is the very large yields of protein that can readily be obtained. The
protein produced in inclusion bodies is also easily purified and so it would make an
excellent source of MOMP. This would make it possible to pursue crystallisation
studies and more detailed analyses of MOMPs function as a porin and possible adhesin




Chlamydial infections represent a major global health problem, with the different
species responsible for a wide range of human and animal diseases. MOMP is the
immunodominant chlamydial protein, with potential structural and functional roles as a
porin, adhesin and, as part of the COMC, providing strength and osmotic stability to the
cell. MOMP is therefore considered to be a primary vaccine target. Constraints in the
culturing of the intracellular bacteria and difficulties in purifying MOMP and separating
it from other outer membrane proteins have made it difficult to effectively study MOMP
biochemistry and develop its vaccine potential. The establishment of a reliable
recombinant expression system would greatly facilitate the furtherance of these aims.
A topology prediction for C. trachomatis MOMP has been presented here, based on
analysis of the primary amino acid sequence by three artificial neural network programs.
The resulting model complied well with the general rules for P-barrel membrane
proteins, and with other experimental data concerning MOMP. MOMP was predicted to
be a 16-stranded P-barrel with an average strand length of 9 amino acids, none ofwhich
contained proline residues. The "aromatic belts" of outward facing aromatic residues
seen in other porins were also observed here. Crucially, the highly immunogenic VS
domains were on the long extracellular loops and two of the cysteine residues were on
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periplasmic turns, allowing important interactions with the periplasmic OmcB and
OmcA on the inner leaflet of the outer membrane. Most other cysteine residues were on
extracellular loops, and so could be available for intersubunit cross-linking.
A large range of chlamydial porin constructs have been made. These include ompA
from a further two species of chlamydiae (C. trachomatis and C. muridarum) and porB,
all without any signal sequence, to add to the two mature ompA constructs available in
the lab (Ch. abortus and Ch. pneumoniae). Constructs containing ompA and porB genes
including their native chlamydial signal sequence or an E. coli signal sequence have also
been made (ompA from C. trachomatis, C. muridarum and Ch. abortus). A mutant C.
trachomatis ompA, with all nine cysteine residues converted to alanine residues, has
been produced in both the mature form of the gene without a signal sequence, and with
both the native and E. coli signal sequences. Finally, internal mutagenesis on the C.
trachomatis ompA with the chlamydial leader has been used to create four constructs,
each lacking one of the MOMP VS domains.
Two different approaches to the production of recombinant MOMP have been developed
using these constructs. The expression ofmature MOMP and PorB as inclusion bodies
was optimised to give a large yield of recombinant protein dissolved in chaotrope. The
protein was expressed in porin-deficient Aomp8 BL21 cells and processed through a
rigorous clean up protocol to achieve a high level of purity. High levels of recombinant
protein could be produced from all mature constructs by this method. Recombinant
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porin expressed with a signal sequence was targeted to the membrane fraction of the
cell. This method of expression inhibited both the growth rate of the bacteria and cell
survival. The use of the E. coli ompT signal sequence rather than the chlamydial leader
helped to prevent this. There was considerable variability between constructs. C.
trachomatis and C. muridarum MOMP expressed well by this method, PorB with the
ompT leader expressed less well, and Ch. abortus MOMP could not be expressed at all.
The production of the ompT leadered C. trachomatis MOMP was further optimised to
increase the yield of protein fully processed to its mature form. This included reducing
the temperature of induction to 16°C, and culturing the bacteria in an alternative growth
medium.
Outer membrane-expressed C. trachomatis MOMP was demonstrated to be surface
exposed in intact BL21 cells. Membrane insertion was temperature dependent. The
oligomerisation of MOMP examined directly from the membrane was similar to what
previously observed with MOMP in C. trachomatis EBs, and protein solubilised in
detergent from the E. coli outer membrane formed porin-like channels in a planar lipid
bilayer. Together these results strongly suggest that recombinant MOMP produced by
this method is folding and inserting into the outer membrane in a native-like manner.
However, the oligomerisation of detergent-solubilised MOMP is highly condition
dependent, and the choice of detergent and redox potential influence subunit association.
The cysteine-less MOMP was able to insert into the membrane, indicating disulphide
bonds are not essential for at least the early part of the folding pathway. Similarly the
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VS domain deletion mutants were showed to be surface exposed when expressed in
BL21s, demonstrating that they are not, at least individually, essential for folding.
MOMP solubilised in GuHCl was screened to optimise conditions for refolding into its
native tertiary structure. Numerous conditions were examined, including pH, salt
concentration, addition of chaotrope, detergent choice and concentration and redox state.
CD analysis of the final folded C. muridarum MOMP assigned p-structure of 65%, a
value consistent with that obtained from native MOMP and other porins. This refolded
MOMP was composed of SDS-resistant, heat-modifiable trimers that were further cross-
linked into a large oligomers. Both trimer and oligomer dissociated into monomers in
the presence of reducing agent, suggesting MOMP is forming disulphide bond mediated
complexes, as in the native environment. Large quantities of refolded MOMP could be
obtained by this method.
8.2 Discussion
Recombinant MOMP has been successfully produced by two different expression
methods, with in vivo and in vitro (re)folding. There are advantages to each method, and
the protein produced can be put to different uses. MOMP expressed via inclusion bodies
has much higher yield and purity than outer membrane expressed MOMP. This makes it
useful for bulk protein production and structural studies, which require larger quantities
of protein and more homogenicity than that observed in the in vivo folded MOMP. It is
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also the only route possible for Ch. abortus MOMP, which failed to express at all in the
membrane. However, the large oligomers formed make it difficult to manipulate and
difficult to study the biochemistry of MOMP. The conditions for in vitro refolding will
not necessarily apply to MOMP from all the species expressed, and in particular are
likely to be different for PorB. The screening and optimisation of folding would
therefore need to be repeated, possibly for each protein. This would be highly time
consuming, and yet still may not ultimately be successful for all constructs.
Membrane expressed protein may be more appropriate for examining the biology of
MOMP. The yield of protein is not as high as for IB produced MOMP, but it is
sufficient for biochemical applications. It has already been demonstrated that the system
can tolerate substantial internal mutagenesis, and still process protein and insert it into
the outer membrane. Protein appropriate for electrophysiological analysis can be
produced by this method, allowing detailed analysis of the function of mutants, which
cannot be obtained as effectively any other way. MOMP seems to behave in the
membrane in a similar way to that in chlamydial EBs. As the EBs represent the
infectious stage of the chlamydial lifecycle, this system could be useful for the
development of vaccines against the organism, acting as cellular "mimics" for the
chlamydiae themselves, but much easier to work with. This would also prove useful for
studying the antigenic and adhesin properties ofMOMP without interference from other
chlamydial surface molecules.
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Combining data from both systems gives some insights into the biochemistry ofMOMP,
in particular concerning the role of the conserved cysteine residues. CD analysis of
refolding conditions demonstrated that some disulphide bonding stabilises the secondary
structure of MOMP. Cysteine-less C. trachomatis MOMP (M9-MOMP), and C.
muridarum MOMP in DTT, showed similar (3-structural content (35% and 34% in 1 x
CMC LDAO, respectively). Altering the redox potential surrounding C. muridarum
MOMP resulted in a large increase in (3-structure (59% in 1 x CMC LDAO). Disulphide
bonds also stabilise the tertiary structure of MOMP. Reducing C. trachomatis MOMP
from outer membranes resulted in the collapse of the SDS-resistant folded monomer to
denatured monomer. The oligomers of various subunit multiples were also denatured by
reducing agent, but not by boiling. Likewise, the large oligomers formed by MOMP
when it was refolded from IBs dissociated into monomers when disulphide bonds were
reduced. Together these data suggest that disulphide bonds are important for forming
inter-subunit connections. Overall, cysteine residues are clearly important at several
levels for the structure and/or stability ofMOMP.
In detergent solubilised MOMP, it seems likely that a trimer is the preferable structure,
as previous work, Zwittergent 3,14-solubilised MOMP and refolded MOMP have all
displayed trimeric properties. In CD analysis LDAO was more destabilising to the
protein than other detergents, which may explain the difference in subunit associations
seen in LDAO-solubilised MOMP. However, this is not proven. MOMP examined
directly from chlamydial and E. coli membranes showed no preference for trimers, and
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results presented here indicated that detergent solubilised MOMP may not be fully
accessible to DTT in the solution. Which disulphide bonds have remained intact in these
experiments is critical to establishing the accuracy of the structural prediction. The
notion of a trimeric MOMP should therefore be considered with caution until these
difficulties have been resolved.
8.3 Future work
Refolded IB protein is already being subjected to further structural studies. Early
crystallisation trials have been started, using both standard oligomeric, refolded MOMP
and MOMP that has been reduced after refolding (to separate the oligomers, but
hopefully without completely denaturing the protein). Obtaining a crystal structure for
MOMP would be invaluable to the study of the protein and of chlamydial membrane
structure. Refolding screening will also be started for other species of MOMP. The
availability of several versions will increase the chances of successful crystallisation,
and there may also be interesting differences between the species.
The outer membrane expression system will also be extended to include the different
species of MOMP, PorB and mutants. Further electrophysiological analysis of C.
trachomatis MOMP will be used to examine channel properties such as ion selectivity,
subunit number and cooperation, and gating in the presence and absence ofDTT. Some
of these properties have been measured from the native porin, and so will further
confirm correct folding and function. Others can be used to examine differences
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between MOMP and other porins. C. muridarum MOMP and PorB can already be
produced by this expression system, and will be analysed in a similar manner to C.
trachomatis MOMP. The predicted selectivity of PorB can also be tested by these
methods.
In order to further examine the role of cysteine residues and disulphide bonds in MOMP
structure and function, a better method for controlling the reduction/oxidation level is
required. Concerns have been expressed here about restricted access for reducing agent
in the detergent solubilised experiments. Additionally, protein was oxidised simply by
exposure to air in the absence of reducing agent. Alternative mechanisms for oxidising
the protein in a more controlled manner should be explored. Alkylating agents could be
used to block thiol groups without concerns about the deterioration ofDTT over time in
solution. The level of cysteine bond formation could be tested by several means,
including mass spectroscopy. However, near UV CD analysis may be a more
appropriate method, as it is faster and cheaper, and the sample can be recovered
afterwards.
A major difficulty in working with and analysing MOMP in these systems is trying to
resolve the influences of the predicted intra- and inter-molecular disulphide bonding. A
useful development would be to create a mutant MOMP that contains only the cysteine
residues for an intra-molecular bond, giving a stable monomer without the complications
of extensive subunit cross-linking. This could be achieved by "adding back" pairs of
cysteine residues to the M9-MOMP mutant. The topology prediction shows there are
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relatively few candidates for such a bond. For example, the two periplasmic cysteine
residues are on opposite sides of the p-barrel and could not form an intra-molecular
bond. Such a model would be much more tractable than "wild type" protein, and could
be used for several purposes. These could include determining the preferred
oligomerisation of MOMP outside the highly cross-linked network of the chlamydial
envelope, and providing a form of the protein that may be easier to use for
crystallisation. Circular dichroism could again be used to monitor the formation of any
disulphide bonds and stopped-flow CD analysis could provide interesting insights into
the folding process.
8.4 Conclusion
This thesis has described the development of two different systems for the production of
recombinant chlamydial MOMP. Both methods have generated folded MOMP with
characteristics comparable to the native protein. The work here provides a strong base
for further analysis of the properties of MOMPs, some of which are unique amongst
porins, and a useful source of recombinant MOMPs for future vaccine development.
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Appendix A: Secondary structure prediction raw data
A.1 Diederichs topology prediction data
residue # z coordinate residue # z coordinate residue # z coordinate residue # z coordinate
1 0.135 41 0.369 81 0.666 121 0.417
2 0.141 42 0.352 82 0.652 122 0.444
3 0.168 43 0.365 83 0.665 123 0.415
4 0.152 44 0.353 84 0.551 124 0.414
5 0.160 45 0.308 85 0.594 125 0.459
6 0.209 46 0.332 86 0.673 126 0.400
7 0.293 47 0.325 87 0.711 127 0.377
8 0.590 48 0.342 88 0.742 128 0.415
9 0.584 49 0.321 89 0.658 129 0.339
10 0.449 50 0.354 90 0.613 130 0.252
11 0.344 51 0.390 91 0.560 131 0.248
12 0.319 52 0.438 92 0.546 132 0.370
13 0.285 53 0.388 93 0.492 133 0.335
14 0.232 54 0.469 94 0.510 134 0.358
15 0.228 55 0.466 95 0.617 135 0.381
16 0.264 56 0.492 96 0.581 136 0.403
17 0.258 57 0.475 97 0.576 137 0.480
18 0.274 58 0.438 98 0.490 138 0.447
19 0.363 59 0.500 99 0.523 139 0.520
20 0.439 60 0.499 100 0.474 140 0.476
21 0.548 61 0.425 101 0.341 141 0.638
22 0.586 62 0.503 102 0.349 142 0.696
23 0.610 63 0.453 103 0.357 143 0.709
24 0.703 64 0.568 104 0.360 144 0.749
25 0.725 65 0.628 105 0.382 145 0.758
26 0.832 66 0.641 106 0.409 146 0.706
27 0.860 67 0.703 107 0.302 147 0.563
28 0.859 68 0.728 108 0.385 148 0.504
29 0.863 69 0.747 109 0.355 149 0.454
30 0.857 70 0.760 110 0.256 150 0.419
31 0.843 71 0.709 111 0.297 151 0.437
32 0.800 72 0.699 112 0.280 152 0.417
33 0.706 73 0.606 113 0.327 153 0.454
34 0.568 74 0.560 114 0.262 154 0.448
35 0.495 75 0.580 115 0.313 155 0.429
36 0.371 76 0.602 116 0.424 156 0.387
37 0.341 77 0.565 117 0.311 157 0.402
38 0.424 78 0.685 118 0.337 158 0.376
39 0.399 79 0.672 119 0.392 159 0.452
40 0.461 80 0.617 120 0.394 160 0.400
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residue # z coordinate residue # z coordinate residue # z coordinate residue # z coordinate
161 0.370 201 0.536 241 0.766 281 0.677
162 0.357 202 0.528 242 0.612 282 0.579
163 0.361 203 0.519 243 0.589 283 0.580
164 0.345 204 0.518 244 0.643 284 0.547
165 0.289 205 0.511 245 0.672 285 0.494
166 0.258 206 0.423 246 0.578 286 0.470
167 0.206 207 0.406 247 0.561 287 0.473
168 0.224 208 0.443 248 0.453 288 0.492
169 0.235 209 0.458 249 0.387 289 0.424
170 0.251 210 0.531 250 0.344 290 0.437
171 0.338 211 0.554 251 0.296 291 0.417
172 0.363 212 0.518 252 0.286 292 0.413
173 0.360 213 0.544 253 0.268 293 0.363
174 0.290 214 0.558 254 0.240 294 0.343
175 0.321 215 0.500 255 0.198 295 0.347
176 0.359 216 0.454 256 0.221 296 0.358
177 0.430 217 0.471 257 0.259 297 0.380
178 0.491 218 0.451 258 0.234 298 0.413
179 0.563 219 0.475 259 0.225 299 0.548
180 0.546 220 0.434 260 0.211 300 0.558
181 0.514 221 0.492 261 0.235 301 0.471
182 0.517 222 0.506 262 0.238 302 0.492
183 0.452 223 0.430 263 0.257 303 0.534
184 0.344 224 0.414 264 0.248 304 0.613
185 0.373 225 0.392 265 0.250 305 0.676
186 0.354 226 0.350 266 0.263 306 0.664
187 0.440 227 0.362 267 0.334 307 0.659
188 0.543 228 0.426 268 0.314 308 0.631
189 0.607 229 0.490 269 0.349 309 0.729
190 0.489 230 0.484 270 0.387 310 0.739
191 0.502 231 0.596 271 0.438 311 0.644
192 0.436 232 0.591 272 0.404 312 0.600
193 0.405 233 0.632 273 0.452 313 0.535
194 0.471 234 0.640 274 0.474 314 0.476
195 0.606 235 0.720 275 0.497 315 0.446
196 0.543 236 0.648 276 0.523 316 0.406
197 0.629 237 0.709 277 0.510 317 0.322
198 0.625 238 0.775 278 0.682 318 0.308
199 0.541 239 0.763 279 0.655 319 0.277
200 0.556 240 0.773 280 0.637 320 0.323
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A.2 TMBETA prediction data
Residue # Amino acid Probability Beta strand? Residue # Amino acid Probability Beta strand?
1 L 0 no 21 F 0.026523 no
2 P 0 no 22 G 0 no
3 V 0 no 23 G 0 no
4 G 0 no 24 D 0 no
5 N 0 no 25 P 0 no
6 P 0 no 26 C 0 no
7 A 0 no 27 D 0 no
8 E 0 no 28 P 0 no
9 P 0.000001 no 29 C 0 no
10 S 0.043363 no 30 A 0 no
11 L 0.701077 yes 31 T 0 no
12 M 0.97126 yes 32 W 0 no
13 1 0.999983 yes 33 c 0 no
14 D 0.999075 yes 34 D 0 no
15 G 0.999579 yes 35 A 0.000001 no
16 I 0.999923 yes 36 I 0.891532 yes
17 L 1 yes 37 S 0.627244 yes
18 W 1 yes 38 M 1 yes
19 E 0.999999 yes 39 R 1 yes
20 G 0.999267 yes 40 V 1 yes
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Residue # Amino acid Probability Beta strand? Residue # Amino acid Probability Beta strand?
41 G 0.999902 yes 91 M 0.999931 yes
42 Y 0.996885 yes 92 Q 0.999981 yes
43 Y 1 yes 93 D 0.273308 no
44 G 0.999999 yes 94 A 0.000603 no
45 D 0.99824 yes 95 E 0.028411 no
46 F 0.996786 yes 96 M 0.745253 yes
47 V 0.999997 yes 97 F 0.996383 yes
48 F 0.999591 yes 98 T 0.987616 yes
49 D 1 yes 99 N 0 no
50 R 0.99999 yes 100 A 0.000098 no
51 V 0.999995 yes 101 A 0 no
52 L 0.977549 yes 102 C 0 no
53 K 0.999989 yes 103 M 0.000001 no
54 T 0.999997 yes 104 A 0.001068 no
55 D 0.662277 yes 105 L 0.999791 yes
56 V 0.000002 no 106 N 0.999967 yes
57 N 0.024001 no 107 I 1 yes
58 K 0.999735 yes 108 W 0.999919 yes
59 E 0.999972 yes 109 D 0.983935 yes
60 F 0.999938 yes 110 R 0.865765 yes
61 Q 0.978604 yes 111 F 0.999919 yes
62 M 0.990672 yes 112 D 0.010468 no
63 G 0.003673 no 113 V 0 no
64 A 0.000001 no 114 F 0.020018 no
65 K 0.000001 no 115 C 0.008333 no
66 P 0.000003 no 116 T 0.000003 no
67 T 0.000002 no 117 L 0.000143 no
68 T 0.000035 no 118 G 0.00046 no
69 D 0 no 119 A 0.338433 no
70 T 0 no 120 T 0.994593 yes
71 G 0 no 121 S 0.991135 yes
72 N 0.000001 no 122 G 0.991119 yes
73 S 0 no 123 Y 0.997532 yes
74 A 0 no 124 L 0.993318 yes
75 A 0 no 125 K 0.994921 yes
76 P 0 no 126 G 0.055222 no
77 S 0.000036 no 127 N 0.000447 no
78 T 0.06596 no 128 S 0.054853 no
79 L 0.09359 no 129 A 0.143232 no
80 T 0.961543 yes 130 S 0.120573 no
81 A 0.379301 no 131 F 0.968284 yes
82 R 0.000004 no 132 N 0.999681 yes
83 E 0 no 133 L 0.999977 yes
84 N 0 no 134 V 1 yes
85 P 0.000004 no 135 G 1 yes
86 A 0.000003 no 136 L 0.999939 yes
87 Y 0.000064 no 137 F 0.997708 yes
88 G 0.999995 yes 138 G 0.112499 no
89 R 1 yes 139 D 0 no
90 H 0.999914 yes 140 N 0.000001 no
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Residue # Amino acid Probability Beta strand? Residue # Amino acid Probability Beta strand?
141 E 0.000009 no 191 F 0.999965 yes
142 N 0.000001 no 192 Q 0.99984 yes
143 Q 0.135274 no 193 Y 0.98215 yes
144 K 0.994528 yes 194 A 0.999092 yes
145 T 0.998401 yes 195 Q 0.000033 no
146 V 0.852921 yes 196 s 0.000018 no
147 K 0.947027 yes 197 K 0.00001 no
148 A 0.991556 yes 198 P 0.000018 no
149 E 0.009412 no 199 K 0.000076 no
150 S 0.000263 no 200 V 0.932613 yes
151 V 0.001216 no 201 E 0.203022 no
152 P 0.00007 no 202 E 0.99887 yes
153 N 0.00001 no 203 L 0.999967 yes
154 M 0.912405 yes 204 N 0.794554 yes
155 S 0.000717 no 205 V 0.205572 no
156 F 0.553716 yes 206 L 0.000007 no
157 D 0.065684 no 207 C 0 no
158 Q 0.0132 no 208 N 0 no
159 S 0.999801 yes 209 A 0 no
160 V 0.999865 yes 210 A 0.000254 no
161 V 1 yes 211 E 0.600644 yes
162 E 1 yes 212 F 0.997304 yes
163 L 0.999998 yes 213 T 0.999775 yes
164 Y 0.999991 yes 214 I 0.000089 no
165 T 0.999748 yes 215 N 0.000431 no
166 D 0.970545 yes 216 K 0.000016 no
167 T 0.051384 no 217 P 0.00007 no
168 T 0.999054 yes 218 K 0.00206 no
169 F 0.999225 yes 219 G 0.376327 no
170 A 1 yes 220 Y 0.769769 yes
171 W 0.999981 yes 221 V 0.998698 yes
172 S 0.999992 yes 222 G 0.999953 yes
173 V 0.999996 yes 223 K 0.718313 yes
174 G 0.995633 yes 224 E 0.951607 yes
175 A 0.091799 no 225 F 0.036892 no
176 R 0.999725 yes 226 P 0.088799 no
177 A 1 yes 227 L 0.003714 no
178 A 0.997113 yes 228 D 0.118682 no
179 L 0.969085 yes 229 L 0.000087 no
180 W 0.256853 no 230 T 0.978269 yes
181 E 0 no 231 A 0.001874 no
182 C 0 no 232 G 0.00367 no
183 G 0 no 233 T 0.000397 no
184 C 0 no 234 D 0.000084 no
185 A 0 no 235 A 0.000005 no
186 T 0.000062 no 236 A 0.000004 no
187 L 0.000533 no 237 T 0.001412 no
188 G 0.959657 yes 238 G 0.00045 no
189 A 0.998387 yes 239 T 0.022668 no
190 S 0.999348 yes 240 K 0.00203 no
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Residue # Amino acid Probability Beta strand? Residue # Amino acid Probability Beta strand?
241 D 0.029414 no 291 I 0.953313 yes
242 A 0.000004 no 292 F 0.108673 no
243 S 0.411113 yes 293 D 0.114839 no
244 I 0.096225 no 294 T 0.080032 no
245 D 0.999239 yes 295 T 0.998553 yes
246 Y 0.999798 yes 296 T 0.00001 no
247 H 1 yes 297 L 0.000001 no
248 E 1 yes 298 N 0.000004 no
249 W 1 yes 299 P 0.002574 no
250 Q 0.99976 yes 300 T 0.008378 no
251 A 0.99983 yes 301 I 0.012496 no
252 S 0.991764 yes 302 A 0 no
253 L 0.991586 yes 303 G 0.001463 no
254 A 0.999944 yes 304 A 0.000295 no
255 L 0.999999 yes 305 G 0.006524 no
256 S 0.999999 yes 306 D 0.01631 no
257 Y 1 yes 307 V 0.010385 no
258 R 1 yes 308 K 0.941148 yes
259 L 0.999999 yes 309 T 0.612431 yes
260 N 0.998561 yes 310 G 0.254807 no
261 M 0.226026 no 311 A 0.000682 no
262 F 0.99703 yes 312 E 0.066741 no
263 T 0.993002 yes 313 G 0.957084 yes
264 P 0.041754 no 314 Q 0.08721 no
265 Y 0.991069 yes 315 L 0.12233 no
266 I 0.998817 yes 316 G 0.293475 no
267 G 0.999516 yes 317 D 0.325395 no
268 V 0.999999 yes 318 T 0.194999 no
269 K 1 yes 319 M 0.99997 yes
270 W 1 yes 320 Q 0.99999 yes
271 s 0.997002 yes 321 I 1 yes
272 R 0.999967 yes 322 V 0.999964 yes
273 A 0.996683 yes 323 s 0.999996 yes
274 S 0.00094 no 324 L 0.999999 yes
275 F 0.001971 no 325 Q 0.999993 yes
276 D 0.000923 no 326 L 0.998562 yes
277 A 0 no 327 N 0.999753 yes
278 D 0.352213 no 328 K 0.658104 yes
279 T 0.047103 no 329 M 0.999978 yes
280 I 0.998673 yes 330 K 0.999848 yes
281 R 0.992073 yes 331 S 0.950136 yes
282 I 0.852299 yes 332 R 0.000009 no
283 A 0.000093 no 333 K 0.000078 no
284 Q 0.000001 no 334 S 0 no
285 p 0.000001 no 335 c 0 no
286 K 0 no 336 G 0 no
287 S 0.000015 no 337 1 0.000299 no
288 A 0.00003 no 338 A 0.105824 no
289 T 0.999841 yes 339 V 0.986488 yes
290 A 0.97466 yes 340 G 0.965498 yes
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Residue # Amino acid Probability Beta strand? Residue # Amino acid Probability Beta strand?
341 T 0.999994 yes 356 R 0.999985 yes
342 T 0.999999 yes 357 L 0.999756 yes
343 1 0.999983 yes 358 I 0.995516 yes
344 V 0.166668 no 359 D 0.081346 no
345 D 0.393379 no 360 E 0.021016 no
346 A 0.000314 no 361 R 0.000591 no
347 D 0.007414 no 362 A 0.999998 yes
348 K 0.001813 no 363 A 0.99516 yes
349 Y 0.999689 yes 364 H 0.99883 yes
350 A 0.999982 yes 365 V 0.997226 yes
351 V 0.999998 yes 366 N 1 yes
352 T 0.999983 yes 367 A 0.999974 yes
353 V 0.999999 yes 368 Q 0.999792 yes
354 E 0.999999 yes 369 F 0.999992 yes
355 T 1 yes 370 R 0.979395 yes
371 F 0.006537 no
Predicted segments:
Segment 1 : LI 1 to G20
Segment 2 : 136 to D55
Segment 3 : L105 to F111
Segment 4 : T120 to K.125
Segment 5 : F131 to F137
Segment 6 : S159 to D166
Segment 7 : T168 to G174
Segment 8 : G188 to A194
Segment 9 : D245 to N260
Segment 10 : Y265 to A273
Segment 11 :M319toS331
Segment 12 : Y349 to 1358
Segment 13 : A362 to R370
A.3 B2TMPRED prediction data
Predicted segments:
Starts - Ends
TM ( 1 ) 38 45
TM ( 2 ) 47 54
TM ( 3 ) 57 62
TM ( 4 ) 89 94
131
TM (5 ) 120 - 125
TM (6) 128 - 137
TM ( 7 ) 159 - 165
TM ( 8 ) 167 - 177
TM (9) 188 - 194
TM( 10) 247 - 262
TM( 11 ) 266 - 275
TM ( 12 ) 319 - 330
TM ( 13 ) 348 - 357
TM ( 14 ) 361 - 370
PrimerJuneSeque ce TR5'sACGATT AGATGTCCG T CCTGTGG G A TR5'asGATTCCCCACAGCTGG TRr-niesGCTAC GAATGGAT TRr-ndeasCTCAGGATGITCTA MU5'sCTCTTGCATCATATGGTGGGGAATC MU3'asCGAICGAACG TC MUr-niesCGCTTAGAGCTA MUr-nieasCTGA CTTGCATGTG TIGCAAA C
PB5sCGTATCTAAAGC PB3asGCTATGCTAAGC ■mC25AsTTCGGCGGAGATCCTA TRC25AasAGTGGCGGICCTCA TRC29AsGATC TGCCATC TTGA TRC23AasGTCACGTGG C TRC33AsCCTGCCGA TGGA TRC33AasCATGCTGATAGCTCAG GG TRC102AsTTACAAA G CGCTGGCATT A TATT TRC102AasATTTCA1GCGTA A TRC115AsCGTTGAPCCAT TRC115AasGGTGGCICAGTA CTC TRC182AsG ACTTTGGGAA TRC182AasAAAGTTGCCGCCAT TRC184AsTTGGGAATACTT AG TRC184AasAGCATTTCC TRC207AsGAATTA CTCGI TRC207AasAAACTCGTG GI TRC335AsAAATCTGGCGTA TGCA TRC335AasCAA TGGT
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nl-TR5s1GAGTTCGCTI G AA CTC G CTGGAI nl-TR3*GACCGTTACGA AATC T nl-TR5s2GAAATCGTTC GIT CTT nl-TR5s3CAGGGTATCCAC GT ot-TR5slTATCGCGATIA GCTCTG GAA ot-TR3asGACCGTTACGA ATAC T ot-TR5s2CTGGGAA CCTGA CT ot-TR5s3GATCGACAAGCTG C nl-PB5sGCCCITATATGGTA nl-PB3asGCTATGCATCCCA GGGA












nl-AB5s1CGGGTTCCGTC CCTTTACAATGGAA nl-AB3asCATGCCATGGTTIC GGAC nl-AB5s2GAATCGTTC GI CTCTT nl-AB5s3GCGAGT CTATACGAT TI








Prima1nameSequence TRvslSsATAAGTP:GCOGCC TRvslSasGTA GCTG CCGIAA TRvsl3slAGAGAGTCCCTACCA TRvsljfa lCTGATGCCGATC TRvsl3s2GAGA TCCCGATG TG TRvsl3as2CATGCAATG CCG TC GA TRvs23GTTTGGAGAATGATCATCACA TRvs23asGACCGITTGATAT A CTC TRvs3SslATTAACCG CA G ATG TRvs3Sa lCTCTACAAGGGTI TRvs35s2AATACCG CTGGT TRvs35as2GGAAACCTC TGC TCTGG T T TRvs331ACAGATGCT TRvs33aslAGAG CTC TT TRvs33s2GATCGA ACT TRvs33a 2CAAGAGTC TGTC TRvs45CGAGCA CTTAGTT TRvs4SaGCTATACGCG AT GACGTCAACT CG TRvs43GGTCAGTCAAGTTTCC TRvs43aGGAAACATTTGCCA
MehingtenpCQBgt cjmSti^ivnealiiigt npG 669Ageiffl 669 720-65 720 7194eT65 719 63.1Mi33 63.1 620-55 620 67.1Ait-E® 67.1 70.7-65 70.7 719Af-H65 719 706jfaf-H65 706 720Ait-E65 720
Appendix C: C. trachomatis MOMP Internal mutagenesis





Green circles are cysteine residues. They are mutated to alanine residues in M9-MOMP.
Grey circles are portions of VS domains digested out.
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Appendix D: Foldlt reagents and data
D.1 Combinations of reagents in Foldlt screen
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D.2 Spectroscopic data
Foldit Absorbance at
Reagent 400nm
Combination MP M9
1 0.031 0.007
2 0.107 0.240
3 0.020 0.070
4 0.008 0.008
5 0.841 0.370
6 0.020 0.012
7 0.017 0.014
8 0.590 0.324
9 0.081 0.100
10 0.022 0.023
11 0.013 0.015
12 0.059 0.096
13 0.033 0.015
14 0.503 0.149
15 0.440 0.195
16 0.019 0.023
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